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ABSTRACT 
Stroke continues to place a large burden on society, ranking as the third leading cause of 
death in Australia, and accounting for around 7% of all deaths in the year 2017. The burden 
of stroke has considerably reduced over time, however, which has been partially attributed to 
advances made in the field of acute stroke care. Regrettably, such advances (e.g. the advent 
of acute stroke units, thrombolysis) have not been uniformly distributed throughout our 
society. Indeed, there is some evidence to suggest that rural areas have comparatively poor 
access to such interventions. It remains unclear, however, as to what the extent of these care 
disparities are, and what impact they may be having on patient outcomes. The purpose of this 
body of work was to characterise and contrast the care provided to, and outcomes of, people 
with stroke across geographical settings (e.g. with varying degrees of rurality). Doing so will 
indicate whether patients’ hospital care and outcomes contribute to wider geographical 
disparities in health. Recommendations produced by this thesis will also assist clinicians and 
policymakers to improve the delivery of stroke services in both urban and rural settings. 
In order to address these objectives, a systematic review was conducted as a way of 
characterising the existing body of literature. Several databases, including CINAHL, PubMed 
and Scopus were systematically searched for published and unpublished literature until 9th 
December 2017. Studies were included if they compared the acute care provided to, or 
outcomes of, patients hospitalised for stroke in urban versus rural settings. A total of 28 
studies were included in the review (16 on care, 12 on outcomes). This review showed that 
with few exceptions, studies addressing the provision of care suggested that rural patients 
have less access to most aspects of acute stroke care. At the same time, studies reporting 
urban-rural differences in patient outcomes were inconsistent in their findings.  
Capitalising on a number of gaps identified in the systematic review, a study was 
conducted to describe the regional differences in acute stroke care and outcomes within the 
xix
Australian state of Tasmania. This entailed a retrospective case note audit of 395 acute stroke 
cases from all four of Tasmania’s major public hospitals. Sixteen care processes were 
recorded, which covered time-critical treatment, allied health interventions, and secondary 
prevention. Outcome measures were assessed using 30-day mortality and discharge 
destination, both of which were analysed for differences between urban and rural hospitals 
using logistic regression models. Results of the audit indicated that no patients in rural 
hospitals were administered thrombolysis, and that these hospitals also did not have acute 
stroke units. With few exceptions, patients’ access to the remaining care indicators was 
comparable between regions. After adjusting for confounders, there were no significant 
differences between regions in terms of 30-day mortality (OR = 0.99, 95% C.I. 0.46-2.18) or 
discharge destination (OR = 1.24, 95% C.I. 0.81-1.91). Overall, the findings from this study 
indicated that with the exception of acute stroke unit care and thrombolysis, stroke care 
within Tasmania’s urban and rural hospitals was broadly similar. No significant differences 
were found between regions in terms of patient outcomes. 
Upon completion of the medical record audit, the primary researcher had a set of 
quantitative findings, but little understanding of how the experiences of clinicians delivering 
care differed between regions. In order to address this, a sequential-explanatory approach was 
used to understand the local barriers and facilitators to providing care in urban and rural 
settings. A total of two focus groups and five individual interviews were conducted with 
Tasmanian clinicians from the subject hospitals (one urban, two rural) used in the initial 
study. An inductive process of thematic analysis was then used to identify themes and 
subthemes across the data set. Four major themes were isolated from analysis of the data: 
systemic issues, clinician factors, additional support, and patient factors. Overall, the findings 
suggested that acute stroke care within the study’s urban hospital was structured and 
comprehensive, aided by the hospital’s acute stroke unit and specialist nursing support. In 
xx 
contrast, care provided in the study’s rural hospitals was somewhat less sophisticated, and 
often constrained by an absence of infrastructure or poor access to existing resources. 
The main limitation of the initial Tasmanian-specific medical record audit was its 
relatively small sample from only four hospitals. In order to address this limitation, the 
primary researcher collaborated with the Australian Stroke Clinical Registry (AuSCR) on a 
study using data from this registry. This study utilised data submitted by 50 hospitals (25 
urban, 25 rural) during the period January 2010 to December 2015. Data in relation to four 
care processes were analysed, and patient outcomes were assessed using mortality at intervals 
of 7, 30, 90 and 180 days. Data in relation to participants’ health-related quality of life 
(HRQoL) was also collected at follow up using the EuroQoL-5 dimension-3 level (EQ-5D-
3L) instrument, while an overall measure of perceived health was obtained using the visual 
analog scale (VAS). Of the 28,115 patients, 8,159 (29%) were admitted to hospitals located 
within rural areas. Compared to those admitted to urban hospitals, patients in rural hospitals 
less often received thrombolysis if an ischaemic stroke (urban 12.7% vs rural 7.5%, p<0.001) 
or received treatment in stroke units (urban 82.2% vs 76.5%, p<0.001), and fewer were 
discharged with a care plan (urban 61.3% vs 44.7%, p<0.001). No significant differences 
were found in terms of survival or overall self-reported quality of life. In conclusion, rural 
access to recommended components of acute stroke care was comparatively poorer; however, 
as was the case in the initial study, this did not appear to impact health outcomes at 
approximately 6 months. 
This thesis demonstrates that when compared to hospitals located in urban areas, 
those in rural areas typically provided a basic form of acute stroke care, with reduced access 
to stroke unit care and thrombolysis. An increased use of telestroke, coupled with a more 
efficient use of existing resources would greatly help to improve the state of stroke care in 
rural areas. No regional differences in patient outcomes were reported in either of the 
xxi 
quantitative studies. This finding was consistent with previous research; however, it may 
have been influenced by methodological limitations, particularly relating to statistical power 
to detect differences in outcomes. Similarities in patient outcomes between regions should 
not be taken as that both regions have access to a commensurate level of care, when in fact, 
the level of care differs markedly between regions. The urban-rural disparity in stroke care 
must be addressed now, while it is primarily an issue of thrombolysis and stroke unit care, as 
the disparity can only be expected to grow with the advent of new therapies. 
1. CHAPTER ONE: Introduction
Cardiovascular disease is a leading cause of disease burden in Australia, accounting for over 
one million hospitalisations during 2016-17 (1). Within the broader category of 
cardiovascular disease is stroke, currently the third leading cause of death in Australia (2) and 
a condition which disproportionately affects individuals from rural and remote areas (3).  
1.1 An Overview of Stroke 
The World Health Organization (WHO) defines stroke as “rapidly developing clinical signs 
of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to 
death, with no apparent cause other than that of vascular origin” (4). In more simple terms, 
stroke is a form of cerebrovascular disease in which the brain’s blood supply is interrupted 
unexpectedly (5). Individuals who have suffered a stroke commonly experience a weakness 
or numbness in their extremities, difficulty speaking, and a loss of vision, among other 
symptoms (6). Stroke can be divided into cases where a blood vessel supplying the brain 
experiences a blockage (known as an ischaemic stroke or cerebral infarction) or a bleed 
(known as a haemorrhagic stroke) (7).  
Ischaemic Stroke is defined by the American Stroke Association (ASA) as “an 
episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction” (8). 
Ischaemic strokes account for around 80% of all stroke cases (9) and have an estimated 30-
day mortality rate of around 14% (10). Ischaemic strokes are further classified into one of 
five categories, using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) 
Classification System (11):  
• Large artery atherosclerosis
• Cardioembolism
• Small vessel occlusion
• Stroke of other, unusual, determined aetiology
• Stroke of undetermined aetiology
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Haemorrhagic Stroke can be further divided into cases of intracerebral haemorrhage 
(approx. 10-15% of cases) and subarachnoid haemorrhage (approx. 5% of cases) (9). 
Intracerebral haemorrhage is defined by the ASA as “a focal collection of blood within the 
brain parenchyma or ventricular system that is not caused by trauma” (8). Subarachnoid 
haemorrhage differs from intracerebral haemorrhage in that it refers to bleeding into the 
subarachnoid space (8). Outcomes for individuals who have suffered a haemorrhagic stroke 
are considerably worse than that for ischaemic strokes, with intracerebral haemorrhage and 
subarachnoid haemorrhage being associated with 30-day mortality rates of 44% and 45%, 
respectively (12, 13).  
Transient Ischaemic Attacks (TIAs) have been defined by the ASA as “brief 
episodes of neurological dysfunction resulting from focal cerebral ischemia not associated 
with permanent cerebral infarction” (14). Recognising TIAs is of great importance, as their 
occurrence is associated with an 8% increase in the risk of stroke at seven days and 17.3% at 
three months (15). 
1.1.1 Diagnosing Stroke 
Stroke is a clinical diagnosis, meaning that a diagnosis is initially formed based on the 
patient’s presenting symptoms (16). Common symptoms of stroke include: motor 
impairments, sensory deficits, speech difficulties, hemianopia, dizziness, gait disturbance, 
convulsion, headache, and difficulty swallowing (17). Most facilities use computed 
tomography (CT) scans and magnetic resonance imaging (MRI) to distinguish between 
ischaemic and haemorrhagic strokes, and to determine the location and magnitude of the 
stroke (18).  
1.1.2 Risk Factors for Stroke 
An individual’s risk profile for stroke is comprised of numerous genetic and lifestyle factors 
which may be modifiable or non-modifiable (19, 20). Of the non-modifiable risk factors, age 
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is perhaps the most often cited; on a global scale, the per 100,000 person-year incidence of 
stroke has been estimated to be 168.75 per in those aged under 75, and 3,113 for those aged 
75 and over (21). There are also marked gender differences in the incidence of stroke; a 
pooled estimate derived from 44 different populations suggested that stroke was 33% more 
incident in males than in females (22). The INTERSTROKE study was a case-control study 
undertaken in 22 countries between 2007 and 2010, with the aim of establishing an 
association between stroke with selected risk factors (23). The findings of INTERSTROKE, 
which were replicated in 2016 (24), indicated that ten risk factors were associated with 90% 
of the risk of stroke of any subtype. These factors were hypertension, current tobacco use, 
obesity (estimated by waist-to hip-ratio measurements), poor diet, physical inactivity, 
diabetes mellitus, excessive alcohol intake, psychosocial factors (psychosocial stress and 
depression), cardiac causes of stroke (e.g. atrial fibrillation) and high cholesterol. Of these 
factors, hypertension, current tobacco use, obesity, poor diet and physical inactivity alone 
accounted for in excess of 80% of the risk of all stroke (Table 1) (23).  
 
Table 1. Risk of stroke associated with risk factors (23) 
 
Risk Factor OR† 99% CI PAR* 99% CI 
History of hypertension 2.64  (2.26–3.08) 34.6%  (30.4–39.1) 
Current tobacco use 2.09  (1.75–2.51) 18.9%  (15.3–23.1) 
Obesity 1.65  (1.36–1.99) 26.5%  (18.8–36.0) 
Poor Diet 1.35  (1.11–1.64) 18.8%  (11.2–29.7) 
Regular physical activity 0.69  (0.53–0.90) 28.5%  (14.5–48.5) 
Diabetes mellitus 1.36  (1.10–1.68) 5.00% (2.6–9.5) 
Alcohol intake (30+ drinks/month) 1.51  (1.18–1.92) 3.8% (0.9–14.4) 
Psychosocial factors - - - - 
          Psychosocial stress 1.30  (1.06–1.60) 4.6% (2.1–9.6) 
          Depression 1.35  (1.10–1.66) 5.2% (2.7–9.8) 
Cardiac causes** 2.38  (1.77–3.20) 6.7% (4.8–9.1) 
High cholesterol 1.89  (1.49–2.40) 24.9%  (15.7–37.1) 
 
†Odds ratio *Population-attributable risk - the independent contribution of each risk factor to the burden of 
stroke worldwide **Includes atrial fibrillation, or flutter, previous myocardial infarction, rheumatic valve 
disease, or prosthetic heart valve. ¶For the protective factor of physical activity, population-attributable risks 
are provided for the group without this factor 
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1.2 Defining Rurality 
‘Rurality’ is a term with a number of definitions and methods of measurement (25). In broad 
terms, ‘rural’ refers to geographic areas which typically have smaller populations in more 
isolated settings, or with limited availability of services (26). It should be noted however, that 
in Australia, the term ‘regional’ is often used by government sources to describe areas which 
would typically be regarded as ‘rural’. This is a departure from the traditional use of the term 
‘regional’, that refers to something “of, relating to, or characteristic of a region or regions” 
(27). The way in which rurality is defined has significant implications for planning, policy 
development and the allocation of resources.  
There are multiple geographic classification systems currently in use within Australia, 
with no universally accepted system (28). The current thesis uses two of these systems to 
delineate between ‘urban’ and ‘rural’ areas of Australia: the Australian Standard 
Geographical Classification Remoteness Area (ASGC-RA) and the Modified Monash Model 
(MMM). The ASGC-RA system was developed by the Australian Bureau of Statistics (ABS) 
in 2001 as a means of allowing quantitative comparisons between ‘city’ and ‘country’ areas 
of Australia (29). Under this system, locations are classified into one of five ‘Remoteness 
Areas’ (RAs), namely: Major Cities; Inner Regional; Outer Regional; Remote; and Very 
Remote. RAs are arranged according to the physical distance of a location from the nearest 
urban centre (access to goods and services) without taking the area’s population into account 
(30). This results in a series of anomalous classifications. For example, the town of Urana 
(population 1,500) and city of Townsville (population 170,000) were allocated to the same 
category, due to their distance from the major cities of Melbourne and Brisbane, respectively 
(31). The ASGC-RA system remained in use until 2011, when it was superseded by the 
Australian Statistical Geography Standard (ASGS), from which the MMM is derived (32). 
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The MMM was developed by Australia’s Department of Health in 2015 in order to 
create a more targeted set of incentives for doctors to relocate to rural areas (33). The MMM 
achieves this by taking the ASGS framework and further differentiating rural areas based on 
population, assigning categories ranging from MM1 (major cities) to MM7 (very remote 
areas) (33). A map of the ASGC Remoteness Areas of Australia, and an overlay of the MMM 
in the state of Tasmania are shown below in Figures 1 and 2, respectively.  
Figure 1. Australian Standard Geographical Classification Remoteness Areas (29) 
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1.3 Regional Differences in Health Status 
Individuals living outside of metropolitan areas often have comparatively poor health 
outcomes. A report from the Australian Institute of Health and Welfare (AIHW) (35) 
suggested that, when compared to individuals who resided in major cities, those in ‘regional’ 
areas were more likely to have several of the stroke factors identified by INTERSTROKE, as 
shown in Figure 3 below. 




















1.4 The Burden of Stroke in Australia 
1.4.1 Stroke Incidence and Prevalence 
As of 2019, Australia does not have a nationwide system in place to monitor the incidence of 
stroke. As an alternative, estimates of stroke incidence are often extrapolated from 
population-specific incidence studies (36), or through the use of algorithms applied to 
administrative data (37). Using the latter method, the AIHW estimated that there were around 
37,800 stroke events during the year 2016, equating to more than 100 events each day (1). 
The prevalence of stroke in Australia is primarily estimated using self-reported data from the 
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Australian Bureau of Statistics’ Survey of Disability, Ageing and Carers (SDAC) (5). An 
estimate based on the 2015 SDAC indicated that 1.7% of the population had experienced a 
stroke at some point during their lives (1). 
1.5 Regional Differences in Stroke Epidemiology 
A recent report commissioned by the Stroke Foundation suggested that stroke incidence rates 
in ‘regional’ areas of Australia are 19% higher than that of metropolitan areas (3). As with 
the incidence of stroke, there are also geographic differences in the prevalence of stroke. A 
2017 report by the Stroke Foundation suggested that stroke is 19% more prevalent in 
‘regional’ areas when compared with metropolitan areas, equating to an additional 345 cases 
for every 100,000 population (3).  
1.5.1 Morbidity and Mortality Resulting from Stroke 
In Australia, disability resulting from stroke is monitored through the SDAC, with additional 
analyses being conducted intermittently by state health authorities (38) and in population-
specific academic studies (39, 40). Data obtained from the 2015 SDAC identified that of 
390,000 individuals who had experienced a stroke, around 40% were currently living with a 
disability (41). Findings from a previous SDAC showed that the three most common forms of 
disability were a ‘restriction in physical activities’, ‘incomplete use of feet or legs’ and an 
‘incomplete use of arms or fingers’, all of which were reported by more than 35% of survey 
respondents (6). In terms of disability-adjusted life years (DALYs), the AIHW ranks stroke 
as the fourth most burdensome condition in Australians aged over 65, sitting behind coronary 
heart disease, dementia and Chronic Obstructive Pulmonary Disease (42). 
In terms of mortality, stroke consistently ranks as one of the top three causes of death 
among Australians when grouped in the broader category of cerebrovascular disease (43). 
This is notable, as approximately 78% of deaths within cerebrovascular disease are 
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attributable to stroke (44). Recent estimates suggest that the stroke mortality rate for 
individuals in metropolitan areas is 47 per 100,000, while the same figure for rural areas was 
19% higher, at 56 per 100,000 (3). A similar pattern can be found in rates of hospitalisation, 
where rates increase in line with patients’ remoteness (as shown Figure 4 below). 
Figure 4. Hospitalisations for stroke per 100,000 population, by remoteness (5) 
1.5.2 Economic Cost of Stroke 
A report commissioned by Australia’s Stroke Foundation estimated that the total financial 
cost associated with stroke in Australia stood at $5 billion during 2012 (45). Of this amount, 
$3 billion was attributed to a loss of productivity, while health and carer costs were estimated 
to be $881 million and $222 million, respectively. Putting these financial costs aside, the 
report noted that the greatest overall cost of stroke was attributed to the loss of healthy life. In 
terms of DALYs, the total burden of disease cost for stroke in Australia during 2012 was 
estimated to be $49.3 billion (45). 
1.5.3 Temporal Trends in the Burden of Stroke 
The incidence of stroke in Australia is an area in which considerable improvements have 
been made over time. Between 1997 and 2016, the national stroke incidence rate dropped 
from 186 to 132 per 100,000 population, representing a 29% reduction (1, 5). Age-
standardised rates of stroke mortality have also markedly declined over time. From 1980 to 
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2016, the number of deaths attributed to stroke fell by three-quarters (74%), as shown in 
Figure 5 below) (41).  
Figure 5. Trends in stroke deaths in Australia, by sex, 1980–2016 (41) 
 
As can be expected, the trend in stroke prevalence is somewhat less positive, with the last 
four iterations of the SDAC all estimating that prevalence rates have remained stable at 
around 1.5% to 2% of the population (46). The proportion of individuals living with a 
disability resulting from stroke has also remained static over time, decreasing slightly from 
45% to 39% between 1998 and 2012 (46). Improvements in stroke patient outcomes have 
been attributed to reductions in modifiable risk factors, greater usage of pharmaceutical 
treatments, and increasingly specialised hospital care, among other factors (5, 47). 
1.6 The Tasmanian Context 
Two of the studies (i.e. Chapters three and four) contained in this thesis relate to the provision 
of stroke care and patient outcomes within the Australian state of Tasmania. Tasmania is 
Australia’s only island state, and as of September 2019, had an estimated population of 
535,000 (48). The median age of Tasmania’s population is 42.3 years, which is the highest of 
























cholesterol, and physical inactivity which are above national averages (3). Given its 
heightened risk profile, it follows logically that the burden of stroke in Tasmania is also 
disproportionately high. As of 2017, Tasmania’s per capita rates of stroke incidence and 
mortality were 13% and 10% higher than national figures.  
1.7 Models of Acute Stroke Care 
Stroke care can be viewed through the prism of Donabedian’s structure-process-outcome 
(SPO) model (50). Developed by physician Avedis Donabedian in 1966 (51), the model has 
had a profound influence on how quality in health care is measured, and is still regarded as a 
dominant paradigm within its field (52, 53). According to the model (illustrated in Figure 6 
below) the elements comprising ‘structure’ influence the degree to which ‘processes’ are 
delivered, while processes, in turn, are said to influence patient outcomes. While the model 
was not designed to access quality in any specific field (51), it has, over time, been validated 
in a host of acute settings, including trauma care (54) and bariatric surgery (55) among others 
(56). Donabedian’s model is illustrated in the context of stroke care in Figure 7 (overleaf) 
from Chimatiro and Rhoda (57). 

























The ‘structure’ component of acute stroke care in Australia is described in the National Acute 
Stroke Services Framework. The Framework was first developed in 2002 by Australia’s 
Stroke Foundation with the aim of guiding “the establishment and evaluation of stroke 
services to support equitable delivery of best practice care” (59). The most recent iteration of 
this document delineates between three different categories of hospital: comprehensive stroke 
centres (CSCs), primary stroke centres (PSCs) and general hospitals (59). The characteristics 
which separate these three types of hospital are numerous and varied (Table 2). In essence, 
however, CSCs are located in large, tertiary care centres which see high volumes of stroke 
patients (e.g. in excess of 350 cases annually), while PSCs are expected in hospitals receiving 
over 75 stroke admissions annually (59). Hospitals receiving under 75 stroke admissions each 
year are unlikely to have enough demand for specialist services such as stroke units, 
clinicians with stroke expertise or advanced neuroimaging. As such, these ‘general hospitals’ 
are encouraged to transfer patients to larger, better equipped hospitals, or alternatively, to 
access specialist input via telestroke services (59).  
1.7.1 Stroke Units 
As noted within Table 2, CSCs and PSCs should be equipped with stroke units (SUs). 
Australia’s Stroke Foundation notes that SUs should have the following characteristics (39): 
1. Dedicated hospital beds located within a geographically defined unit.
2. Multidisciplinary team care by staff with an interest in stroke and/or stroke
rehabilitation. ‘Multidisciplinary’ in this instance refers to medical, nursing and allied
health staff (including occupational therapists, physiotherapists, speech therapists).
3. Multidisciplinary team meetings, which occur at least once weekly.
4. Regular education of staff in matters pertaining to stroke care. This may be in the
form of a stroke in-service program, and/or access to stroke conferences.
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Table 2. Features of hospital stroke services (59) 
Element of service 
Comprehensive 
Stroke Centre Primary Stroke Centre 
General Hospital 
(in regional and rural 
settings where not 
bypassed) 
Receive pre-notification and prepare to rapidly accept 
potential stroke patient from pre-hospital services   
Coordinated emergency department systems 
(includes use of validated screening tools; agreed 
triage categories; rapid imaging; rapid referral and 
involvement of stroke team, protocols for IV 
thrombolysis and ECR intervention/transfer) 
 including code 
stroke activation
and possible direct
transport to CT 
 including code 
stroke activation
and possible direct






Stroke unit    
Rapid access to onsite CT brain (24/7) including CT 










On-site endovascular stroke therapy 24/7# Optional¥  
On-site neurosurgical services (e.g. for 
hemicraniectomy due to large middle cerebral artery 
infarcts) 
 Optional¥  
Ability to provide acute monitoring (telemetry and 
other physiological monitoring) for at least 72 hours   
Acute stroke team   Optional 
Dedicated stroke coordinator position   Optional 
Dedicated medical lead ^   
Access to HDU / ICU (for complex patients)   
Rapid (within 48 hours) Transient Ischaemic Attack 
(TIA) assessment clinics/services (including early access 
to carotid and advanced brain imaging) 
  initial assessment and 
referral 




Optional (if required 
for 24/7 service) 
 
Standardised processes that ensure ALL stroke patients 
are assessed for rehabilitation. This includes use of 
standardised tools to determine individual 
rehabilitation needs and goals (ideally within 48 hours 
of admission). 
  *
Coordination with rehabilitation service providers (this 
should include a standardised process, and/or a 
person, used to assess suitability for further 
rehabilitation). 
  Optional* 
Routine involvement of patients and carers    
Routine use of guidelines, care plans and protocols   
Regular data collection and stroke specific quality 
improvement activities  
Optional 
Access and collaboration with other specialist services 
(cardiology, palliative care, vascular) 
Optional onsite Referral 
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SUs are favoured over conventional ward care, as they have a demonstrable link with 
improved access to the specific processes of acute stroke care, which in turn is associated 
with improved patient outcomes (60, 61). Indeed, SU care is regarded as being the single 
most important intervention available to stroke patients (59). Regrettably, the findings of 
recent Stroke Foundation audits suggest that hospitals in Australia’s rural areas are less likely 
to be equipped with SUs. For example, in 2017, 77% of urban patients and 47% of rural 
patients received stroke unit care, and in 2019 this disparity had widened to 79% and 35%, 
respectively (62, 63). 
1.8 Acute Stroke Care 
Referring once again to Donabedian’s triad (50), the ‘process’ component of acute stroke care 
is embodied by numerous studies sets of guidelines which detail the gold standard of acute 
stroke care. In Australia, the Stroke Foundation’s Clinical Guidelines for Stroke Management 
(herein referred to as the Clinical Guidelines) are the pre-eminent source of research-based 
evidence for acute stroke care. The Clinical Guidelines exist as a set of ‘living guidelines’ 
which are regularly updated with recommendations for and against a wide range of 
interventions (64).  
1.9 Acute Stroke Clinical Care Standard 
With the formation of the Australian Commission on Safety and Quality in Health Care 
(ACSQHC) in 2006, efforts were made to create a concise set of clinical guidelines for acute 
stroke. These guidelines, which would become known as the Acute Stroke Clinical Care 
Standard, detail the essential aspects of acute stroke care using the abovementioned Clinical 
Guidelines as their main source of evidence. The Clinical Care Standard is comprised of 
seven ‘quality statements’, each of which relate to a set of specific care processes (Figure 8).   
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1.9.1 Evidence Base for Clinical Care Standard Items 
1.1.1.1 Quality statement 1 – Early assessment  
• Assessment by ambulance services
The Clinical Guidelines (64) recommend that individuals with suspected stroke should be 
immediately assessed for stroke using a validated stroke screening tool. Several studies (66-
68) have demonstrated that providing hospitals with early notification of suspected stroke
patients reduces the time to administration for reperfusion therapies in eligible candidates. 
• Assessment in the emergency department (ED)
The Clinical Guidelines (64) recommend that individuals with suspected stroke, who have 
been pre-notified to the hospital’s stroke or ED team, should be assessed by these teams upon 
arrival to the hospital. Early assessment for stroke within the ED has been associated with 
improved thrombolysis rates (69, 70). 
1.1.1.2 Quality statement 2 – Time-critical therapy 
• Transport to a hospital able to provide thrombolysis
The Clinical Guidelines (64) recommend that individuals who have a confirmed diagnosis of 
ischaemic stroke, and who appear to be candidates for thrombolysis, should be transported 
via ambulance to a hospital capable of administering thrombolysis. One study (71) reported 
an association between ambulance crews’ prioritisation of stroke patients and improved rates 
of thrombolysis administration.  
• Thrombolysis in ischaemic stroke / Presentation and intravenous thrombolysis within
4.5 hours of symptom onset
The Clinical Guidelines (64) state that individuals with potentially disabling ischaemic 
strokes should be administered thrombolysis, unless contraindicated. Numerous studies have 
found an association between the provision of thrombolysis and a reduction in the odds of 
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death or dependency at 3-6 months post-stroke (72). Thrombolysis is most effective when 
administered within 4.5 hours of symptom onset (72). 
 
• Thrombolysis within 60 minutes of hospital arrival / Time from onset of symptoms to 
thrombolysis 
 
As mentioned above, the Clinical Guidelines (64) recommend the use of thrombolysis for 
ischaemic stroke patients. The findings of multiple clinical trials have indicated that the 
benefits of thrombolysis are most pronounced with earlier intervention (72).  
 
1.1.1.3 Quality statement 3 – Stroke unit care 
 
• Admission into a stroke unit  
 
The Clinical Guidelines (64) regard stroke units as being “the single most important 
recommendation for improving stroke management”. Numerous clinical trials have reported 
an association between stroke unit care and significant reductions in the odds of death or 
dependency (60).   
 
• 90% of acute hospital admissions on a stroke unit 
 
Whilst not featuring in the Clinical Guidelines, this indicator was adopted from the United 
Kingdom’s National Health Service (73). This indicator complements the previous indicator 
by measuring the proportion of patients who spent the majority of their time in hospital on a 
stroke unit. 
 
1.1.1.4 Quality statement 4 – Early rehabilitation 
 
• Assessment for rehabilitation by a physiotherapist within 24–48 hours 
 
The Clinical Care Standard (65) states that individuals admitted for stroke should be 
assessed by a physiotherapist within 24-48 hours of their presentation to hospital. The 
Clinical Care Standard (65) further notes that this early assessment is an important starting 
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point to the acute care management, rehabilitation, and discharge planning process, which 
should improve the appropriateness of the patient’s ongoing management.  
 
• Rehabilitation therapy within 48 hours of initial assessment / Treatment for a 
rehabilitation goal commencing during an acute hospital admission 
 
This indicator measures the proportion of stroke patients who commence rehabilitation 
therapy within 48 hours of their initial assessment, and those who commence therapy at any 
point during their acute admission. Participation in active rehabilitation programs of this kind 
generally means that patients spend less time in bed and more time standing, walking and 
being active, which is itself associated with improved patient outcomes (60, 74, 75). 
 
1.1.1.5 Quality statement 5 – Minimising risk of another stroke 
 
• Discharge on statin, antihypertensive and antithrombotic medications (ischaemic 
stroke) or discharge on antihypertensive medication (haemorrhagic stroke) 
 
The Clinical Guidelines (64) recommend that patients with either haemorrhagic or ischaemic 
stroke should be discharged on medication aimed at lowering their blood pressure. The 
findings of a meta-analysis of 10 randomised controlled trials (RCTs) (76) indicated that the 
use of blood pressure lowering agents was associated with a reduced likelihood of secondary 
stroke and cardiovascular events. For those with ischaemic stroke, the Clinical Guidelines 
(64) recommend that patients should be discharged on statin, antihypertensive and 
antithrombotic medications. Use of these medications has been found to be independently 
associated with a reduced risk of secondary stroke (76-78).  
 
• Discharge on oral anticoagulants for atrial fibrillation 
 
The Clinical Guidelines (64) recommend that stroke patients with comorbid atrial fibrillation 
should be prescribed an anticoagulant medication at discharge. A recent systematic review 
and meta-analysis of 16 RCTs (79) suggested that oral anticoagulants were more effective 
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than placebo and antiplatelet medications at reducing the risk of all forms of secondary 
stroke.  
• Risk factor modification advice before leaving the hospital
The Clinical Guidelines (64) recommend stroke patients are given tailored advice and 
education about lifestyle modification and medications prior to being discharged from 
hospital. The findings of a Cochrane Review (80) suggested that providing such information 
was associated with significant improvements in patient and carer knowledge, and aspects of 
patient satisfaction. 
1.1.1.6 Quality statement 6 – Carer training and support 
• Carer support needs assessment and Carer Training
The Clinical Guidelines (64) recommend that carers of individuals who have experienced a 
stroke be given adequate training on how to provide ongoing care in the community. The 
findings of one RCT suggested that providing carers with such training was associated with 
reduced costs, caregiver burden and improved psychosocial outcomes in care givers and 
patients at one year (81). 
1.1.1.7 Quality statement 7 – Transition from hospital care 
• Written care plan
The Clinical Guidelines (64) recommend that patients who are being discharged home are 
provided with a plan to guide the individual’s care once they have returned to the community. 
The Clinical Care Standard (65) notes that such plans should include rehabilitation goals, 
lifestyle modifications and contact details for ongoing support services, among other items. A 
recent Cochrane review (82) found that providing patients with a discharge plan may result in 
a small reduction in hospital length of stay, whilst also reducing the risk of readmission 
within three months. 
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1.9.2 Monitoring Adherence to Acute Stroke Care Processes 
The Clinical Care Standard described above provides clinicians with a set of essential 
processes of care which should be provided to all patients admitted for stroke in Australian 
hospitals. Of course, the presence alone of the Clinical Care Standard cannot ensure that it is 
adhered to by policymakers, or by clinicians working in the field. Indeed, in order for this to 
happen, it is necessary to collect data on provision of care within the hospital, and feed it 
back to clinicians (83). These data can, in turn, be used as part of quality improvement 
initiatives (Figure 9) (84). In Australia, the provision of evidence-based acute stroke care is 
primarily monitored through two data collection programs: the Stroke Foundation’s Acute 
Audits and the Australian Stroke Clinical Registry (AuSCR). 




1.9.3 Stroke Foundation Acute Audits 
The Stroke Foundation’s Acute Audits are comprised of an organisational survey and a 
clinical audit, both of which are conducted every second year (63). The organisational survey 
assesses ‘structure’ as defined by Donabedian (50), providing information about the resources 
available to deliver acute stroke care, such as the availability of stroke units, imaging services 
and interdisciplinary staff (63). The clinical audit, on the other hand, is concerned with 
Donabedian’s ‘process’ (50), taking 40 random cases per hospital and measuring each site’s 
adherence to 18 care processes derived from the ACSQHC’s Clinical Care Standard (63). 
These audits have a large scope, capturing data on over 35,000 admissions from 120 hospitals 
during the most recent 2019 audit (63). Unfortunately, the utility of the Acute Audits as a 
vehicle for investigating regional variations in acute stroke care and outcomes is somewhat 
limited. This is primarily because the variables needed in order to calculate risk-adjusted 
patient outcomes (e.g. patient age/sex, measures of stroke severity) are either not collected in 
the audits, or are only available to researchers in a summary form.  
1.9.4 The Australian Stroke Clinical Registry  
The AuSCR is a national, non-government clinical registry established in 2009 to monitor the 
care and outcomes of patients admitted for acute stroke in Australia (85). As of 2017, the 
AuSCR had recorded over 30,000 episodes of care recorded from a total of 59 sites (86). The 
AuSCR collects data in relation to four care process measures: intravenous thrombolysis, 
stroke unit care, discharged on antihypertensive medication, and the provision of a discharge 
care plan. A further four variables (i.e. dysphagia, hyperacute aspirin, mobilisation, and anti-
thrombotic medication at discharge) are collected only in hospitals located in the state of 
Queensland (87). The registry is also capable of reporting on patient mortality following 
stroke, as it is routinely linked to the Australian Government’s National Death Index (88). 
Unlike the Stroke Foundation’s audits, the AuSCR’s data collection is continuous, and 
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participating hospitals also have the ability to benchmark their performance against peers 
using a web-based dashboard (85). 
The principal limitation of using the AuSCR to examine regional differences in care 
and outcomes relates to the representativeness of its data. There are significant upfront and 
ongoing costs associated with participation in the AuSCR. As such, hospitals subscribing to 
the registry are likely to be larger sites (i.e. with an ample number of stroke admissions each 
year) and sites with specialist staff who are committed to improving stroke care. 
Notwithstanding, the AuSCR represents the most comprehensive set of data on acute stroke 
care in Australia at present.  
1.10  Unwarranted Variation 
Data collected by the AuSCR and the Acute Audits are primarily used by individual hospitals 
to benchmark their delivery of acute stroke care against that of their peers. Neither of these 
initiatives yield much information about broader, system-wide patterns in access to care and 
patient outcomes, such as the disparity between urban and rural areas. This process is known 
as the study of ‘geographic variation’, or more commonly ‘unwarranted variation’ (89). 
Unwarranted variation can be defined as “wide variations that cannot be explained by illness 
severity or patient preference” (89). Unwarranted variation distinguishes between ‘good’ 
variation which can be explained by differences in clinical need, and ‘bad’ or unwarranted 
variation which cannot, and hence should be reduced (90). As noted in a report by the 
Australian Commission on Safety and Quality in Health Care (91) , there are a host of 
reasons why detecting and addressing Unwarranted variation should be of interest to 
clinicians and policymakers:  
• It may reflect structural factors that mean some have less access to health care than
others.
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• It may mean that factors other than patients’ need or preferences are driving treatment 
decisions, particularly for discretionary interventions. 
• In some cases, variation may reflect evidential uncertainty as to which medical 
intervention is best.  
• Variation in medical practice may mean some people are having unnecessary (and 
potentially harmful) tests or treatments. Or, conversely, that some people are missing 
out on tests and treatments that might be helpful.  
• Variation in practice may also mean that scarce health resources are not being put to 
best use.  
1.11  Synopsis 
Stroke is a leading cause of death and disability in Australia; this is particularly the case in 
the country’s rural areas where it is more prevalent. Reductions in the burden of stroke over 
the past half century have been attributed to increasingly specialised hospital care, among 
other factors. Despite a well-established link between these models of care and improved 
patient outcomes, it is apparent that hospitals in Australia’s rural areas are relatively under-
resourced. What remains uncertain, however, is whether this difference in resourcing has 
resulted in regional differences in access to acute stroke care, and if so, whether there are any 
corresponding disparities in patient outcomes. There is impetus to use the resources available 
to researchers (e.g. the AuSCR) to address the issue of Unwarranted variation in acute stroke 
care within Australia.   
1.12  Critical Appraisal of Existing Studies 
Where stroke is concerned, it remains unclear as to whether differences in the quality of acute 
care (and in turn, differences in hospitalisation outcomes) serve to exacerbate existing 
geographical health disparities. O’Neill and Godden (92) examined patterns of healthcare 
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utilisation and outcomes in Scotland, concluding that when compared with stroke patients in 
urban areas, those from rural and remote areas were not relatively disadvantaged. 
Interestingly, the authors noted that factors including diagnostic uncertainty, and mortality 
occurring prior to hospital notification may have unduly influenced their findings (92). 
In Australia, the Stroke Foundation has previously reported that patients admitted to 
rural hospitals were less likely to receive certain care processes, although no patient outcome 
measures were reported alongside these findings (93). Read and Levy (94) audited the 
medical records of 150 stroke patients from hospitals located in rural and metropolitan areas 
of Queensland. The authors noted that rural patients were less likely to receive a host of care 
processes, including swallow assessments, CT scans with 24 hours of admission, and allied 
health consultations. At the same time, there were no significant differences in patient 
outcomes between regions. Critically, the authors failed to employ any risk adjustment in 
their analyses. Given the need to adjust for case-mix variables (95) (and in particular, stroke 
severity) when comparing stroke patient outcomes, this raises some doubts about the validity 
of the study’s findings. 
More recently, Cadilhac and colleagues (96) observed that stroke patients treated in 
rural Australian hospitals had a relatively high risk of in-hospital mortality, when compared 
to those treated in metropolitan centres. Notably, the authors found that this risk was nullified 
in cases where rural patients received treatment in a SU. One limitation of this study, 
however, is that measures of in-hospital mortality fail to account for patients transferred 
elsewhere for palliation (i.e. referral bias) (97). As such, rates of in-hospital mortality 
reported in this study may have been influenced by metropolitan hospitals’ ability to transfer 
their palliative patients to external facilities. Further, whilst this study reported a positive 
associated between stroke unit care and patient outcomes, it gives no mention to the 
magnitude of this effect. As such, it is possible that the apparent ‘protective’ effect of stroke 
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unit care in this study may have been negligible. The inconsistent findings of previous 
studies, coupled with their methodological shortcomings, provides impetus for further 
research on geographic differences in the quality of acute stroke care, and the associated 
outcomes.  
1.13  Factors Influencing the Delivery of Care 
As mentioned above, several studies have described geographic differences in the quality of 
acute stroke care (93, 94, 96). Comparatively little is known about the factors influencing 
clinicians’ ability to deliver care in different geographic settings. Brems and colleagues (98) 
surveyed 1,500 healthcare professionals working within either urban or rural settings, to 
determine whether they faced different barriers to the provision of care. The authors noted 
that whilst both groups had many barriers in common, the number of barriers perceived by 
clinicians increased in line with their remoteness (98).     
Where acute stroke care is concerned, much of the existing literature has focussed on 
factors influencing the administration of thrombolysis, a treatment for which approximately 
one third of patients qualify (99). Of those studies which have addressed the delivery of acute 
stroke care more comprehensively, time and resourcing constraints were cited as barriers to 
providing care (100, 101). A thorough search identified one study (102) which had addressed 
barriers and facilitators to providing stroke care within a rural setting. Given the limited 
utility of existing studies, coupled with an overall paucity of literature, it remains unclear as 
to whether clinicians working in urban and rural settings encounter similar issues when 
providing care to acute stroke patients.  
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1.14  Aim and specific objectives of the thesis 
The purpose of this body of work is to characterise and contrast the care provided to, and 
outcomes of, people with stroke across geographical settings (e.g. with varying degrees of 
rurality). Doing so will indicate whether patients’ hospital care and outcomes contribute to 
wider geographical disparities in health. Recommendations produced by this thesis will also 
assist clinicians and policymakers to improve the delivery of stroke services in both urban 
and rural settings. 
 
The specific objectives of the thesis are to: 
I. Identify, critique and synthesise literature pertaining to urban-rural differences in 
both the quality of care and outcomes of acute stroke patients. 
II. Describe the regional differences in acute ischaemic stroke care and outcomes 
within the Australian state of Tasmania.   
III. Interview clinicians located in urban and rural settings, to determine which factors 
influence their ability and willingness to provide guideline-recommended acute 
stroke care. 
IV. Compare the processes and outcomes of care in patients with stroke treated in 
urban versus rural hospitals that participate in the Australian Stroke Clinical 
Registry (AuSCR). 
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1.15  Research Design 
Informed by the desire to achieve a pragmatic outcome from the research, a multi-phase, 
sequential-explanatory mixed methods design, as described by Creswell and Plano Clark 
(103), was selected to address the research objectives. This involved two distinct phases of 
data collection (i.e. quantitative followed by qualitative). Phase one was a case note audit of 
stroke patients admitted to urban and rural hospitals in Tasmania, Australia. Phase two 
involved a series of focus groups and interviews with clinicians from the subject hospitals 
used in phase one. An additional quantitative study was then conducted using data from the 
AuSCR, with a view to addressing limitations of the initial case note audit. Lastly, phase 
three was an integration and explanation of the results stemming from the two former phases. 
1.16  Thesis Structure 
Chapter one has summarised the literature, defined key knowledge gaps, and provided a 
rationale for the research approach. Chapter two presents a systematic review on urban-rural 
differences in the quality of care and outcomes of acute stroke patients. Chapter three 
describes the findings of a case note audit on regional differences in acute ischaemic stroke 
care and outcomes within the Australian state of Tasmania. Chapter four reports the findings 
of a qualitative study which aimed to determine which factors influenced urban and rural 
clinicians’ ability and willingness to provide guideline-recommended acute stroke care. 
Chapter five contains a retrospective study comparing the processes and outcomes of care in 
patients with stroke treated in urban versus rural hospitals across Australia, using data from 
the AuSCR. Chapter six discusses the overall findings of the studies included in the thesis in 
the context of the extant literature, before addressing limitations and providing suggestions 
for future research and changes to clinical practice.  
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Chapters one and four are written using the passive voice. Chapters two, three, and five are 
written in the first-person plural, while chapter six is written in the first-person singular. The 
flow of this thesis is illustrated in Figure 9 below.




Tasmanian (DMR) Study 
Qualitative Study National (AuSCR) Study 
General Discussion 
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2. CHAPTER TWO: Urban-rural differences in the care and outcomes of 
acute stroke patients: Systematic review 
 
This chapter reports a systematic review conducted with the aim of identifying, critiquing and 
synthesizing literature relating to urban-rural differences in the quality of care and outcomes 
of acute stroke patients. 
 
This work was published in The Journal of the Neurological Sciences: 
 
Dwyer M, Rehman S, Ottavi T, Stankovich J, Gall S, Peterson G, Ford K, Kinsman L. 
Urban-rural differences in the care and outcomes of acute stroke patients: Systematic 
review. J Neurol Sci. 2019 Feb 15;397:63-74. doi: 10.1016/j.jns.2018.12.021. Epub 
2018 Dec 18. PMID: 30594105. 
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A B S T R A C T
Objective: To describe literature pertaining to urban-rural differences in both the quality of care and outcomes of
acute stroke patients.
Methods: We systematically searched CINAHL, PubMed, ProQuest Dissertations & Theses, and Scopus for pub-
lished and unpublished literature until 9th December 2017. Studies were included if they compared the acute
care provided to, or outcomes of, patients hospitalised for stroke in urban versus rural settings. Abstract, full-text
review, and data extraction were conducted in duplicate. Findings are presented in the form of narrative
syntheses.
Results: A total of 28 studies were included in the review (16 on care, 12 on outcomes). With few exceptions,
studies addressing the provision of care suggested that rural patients have less access to most aspects of acute
stroke care. Studies reporting urban-rural differences in patient outcomes were inconsistent in their findings,
however, few of these studies were primarily focused on the issue of urban-rural disparities. Overall, study
findings did not appear to differ in line with study quality ratings, stroke subtypes included, or how inter-facility
patient transfers were accounted for.
Conclusions: There is convincing, albeit not unanimous, evidence to suggest that stroke patients in rural areas
receive less acute care than their urban counterparts. Despite this, the available data and methodology have
largely not been used to study urban-rural differences in patient outcomes.
PROSPERO registration information: URL: https://www.crd.york.ac.uk/prospero. Unique identifier:
CRD42017073262.
1. Introduction
Individuals living in rural areas are likely to have worse risk factor
profiles [1,2] and higher incidence rates [3–5] for stroke than their
urban counterparts. Evidence from other disease-specific groups sug-
gests that rural populations also have comparatively limited access to
acute care services than urban populations [6–8]. Similar disparities
have previously been reported in relation to acute stroke care [9]. Much
of this literature, however, has focused on specific care processes that
are clearly impacted by geographical factors (e.g. pre-hospital care,
time-critical therapies) [10,11]. Less is known about how acute stroke
care in its entirety differs between urban and rural settings [12].
If there is variation in care delivery between urban and rural set-
tings, the critical issue is whether this results in corresponding differ-
ences in patient outcomes, as reflected by measures including mortality
and readmission rates. Literature in relation to urban-rural differences
in outcomes of acute stroke patients remains equivocal [13–15]. This
may be due, in part, to the methodological shortcomings of some stu-
dies (e.g. poor risk adjustment) [16]. Given that rates of stroke-related
mortality remain higher in rural areas [17–19], there is impetus to
determine whether patients' clinical care and outcomes may be con-
tributing to this divide. The aim of this systematic review was to
identify, critique and synthesize literature pertaining to urban-rural
differences in both the quality of care and outcomes of acute stroke
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2.1. Design and study selection
A literature search was conducted according to the Preferred
Reporting Items for Systematic Reviews and Meta Analyses (PRISMA)
guidelines [20]. The review addressed literature pertaining to 1) urban-
rural differences in the provision of evidence-based acute stroke care,
and 2) urban-rural differences in the outcomes of acute stroke patients.
This review was registered with PROSPERO (CRD42017073262).
2.2. Eligibility criteria
2.2.1. Types of participants
This review considered studies that compared the care provided to,
or outcomes of, individuals admitted to hospitals located in urban and
rural settings following an acute episode of stroke. The authors re-
cognise that definitions of ‘rural’ and ‘urban’ settings (and their various
synonyms) differ markedly between countries; as such, we assumed that
these classifications were meaningful within the context of each study.
No restrictions were imposed on how urban/rural status was defined or
on the unit of analysis used (e.g. patient-level or hospital-level). The
review considered articles that defined stroke using generic terms (e.g.
stroke, cerebrovascular disease, brain attack etc.) and terms used to
describe the following specific diagnoses: transient ischaemic attack,
subarachnoid haemorrhage, intracerebral haemorrhage, and cerebral
infarction. Articles focussing on the broad category of ‘cardiovascular
disease’ and its synonyms were only considered if they made specific
reference to ‘stroke’ or its sub-classifications.
2.2.2. Types of intervention(s)/phenomena of interest
This review considered studies that explicitly compared the care
provided to, or outcomes of, patients within the abovementioned
groups.
2.2.3. Study designs
The current review considered quantitative studies that employed
observational study designs, including ecological studies, cross-sec-
tional studies, case-control studies, and cohort studies.
2.2.4. Outcomes
This review considered studies that reported care process measures
commonly used during episodes of acute hospitalisation for stroke.
These included stroke unit treatment, thrombolysis, venous throm-
boembolism (VTE) prophylaxis, secondary prevention medications (e.g.
anti-hypertensives, anticoagulants) and allied health interventions.
These care processes may have been provided in pre-hospital, emer-
gency department or inpatient settings. In terms of clinical outcome
measures, this review considered studies that reported rates of mor-
tality and readmissions, and patients' discharge destinations following
their acute episode of care. Functional measures were also considered;
these included patients' scores on the following indices: Modified
Rankin Scale (mRS), Barthel Index, and Functional Independence
Measure (FIM).
2.3. Exclusion criteria
We excluded articles which reported variations in the care provided
to (or outcomes of) acute stroke patients between facilities or regions,
without classifying such facilities or regions as being rural or urban (or
their synonyms). We also omitted articles reporting differences in the
outcomes of urban-rural individuals who experienced a stroke, which
were not linked to the individuals' episode of acute hospitalisation (e.g.,
population-level studies comparing stroke deaths between regions).
Where outcome measures were concerned, we excluded studies re-
porting outcome measures that were not risk-adjusted. Articles pub-
lished in languages other than English, and articles with no full text
available were excluded.
2.4. Information sources
Four databases (CINAHL, PubMed, ProQuest Dissertations & Theses,
and Scopus) were searched for relevant white and grey literature, with
additional articles identified via a ‘snowballing’ process. The reference
sections of publications were also screened manually for other relevant
articles.
2.5. Search strategy and study selection
One search strategy was developed for each of the four databases,
with the assistance of a research librarian. The same strategies were
used across both of the review's objectives. All four strategies aimed to
find both published and unpublished studies, published until 9th
December 2017. A copy of the search strategy used in the PubMed
database can be found in Appendix A. The reviewers used Covidence
[21], a web-based tool developed by the Cochrane Collaboration tool to
screen article titles and abstracts in accordance with the criteria listed
above. Three independent reviewers (with the same two per review
objective) were used during the screening process; discrepancies be-
tween these reviewers were resolved through discussion.
2.6. Data extraction and quality appraisal
Two reviewers independently extracted data from each of the in-
cluded studies into a standardised electronic form. This included de-
scriptive data (name of first author, publication year), study design
(country of origin, sample size, covariates used, care processes and/or
patient outcomes of interest), study results and their postulated causes.
Risk of bias within the included studies was assessed using a modified
version of the Newcastle-Ottawa Scale [22], a tool widely used for the
appraisal of non-randomised studies. The tool uses a ‘star’ system in
which a maximum of nine ‘stars’ may be awarded to each study. The
tool assesses three aspects of the study: selection of study groups,
comparability of study groups and ascertainment of outcome of in-
terest. Two independent reviewers (MD, SR) assessed the quality of the
selected literature, before resolving discrepancies via discussion. Stu-
dies assigned ratings of 7–9, 4–6, and 1–3 were considered to be “high”,
“fair” and “low” quality studies, respectively. No articles were excluded
from the review on the basis of their low quality scores.
2.7. Data synthesis
We assessed heterogeneity using the I2 statistic [23], and found that
in light of significant heterogeneity, it was impractical to calculate
pooled estimates of urban-rural care disparities. This objective's find-
ings are presented as a narrative synthesis, where results have been
categorized according to the domain of acute care they relate to. The
researchers attempted to conduct a meta-analysis of studies reporting
urban-rural differences in rates of 30-day mortality; however, a scarcity
of the necessary data rendered this form of analysis infeasible. Ac-
cordingly, this objective's findings are also presented as a narrative
synthesis, in which results have been grouped together based on the
outcome measure being reported.
3. Results
We illustrate the flow of articles through the review screening
process in Fig. 1. Sixteen studies met our inclusion criteria for objective
one (care), while 12 studies were included in objective two (outcomes).
Study findings did not appear to differ with study quality rating, stroke
M. Dwyer et al. Journal of the Neurological Sciences 397 (2019) 63–74
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subtypes included, or how inter-facility patient transfers were ac-
counted for.
3.1. Study characteristics
Of the 16 studies relating to care provision (Table 1), nine (56%)
were from the USA, four (25%) were from Australia, two (12.5%) were
from Canada, and one study was across Finland and Germany. A clear
majority of studies (69%) examined ‘stroke’ generally, while the re-
maining studies restricted their analyses to ischaemic stroke. Studies
describing urban-rural differences in care used a number of different
study designs, of which cross-sectional and cohort studies were the
most prevalent. Of the 12 studies on patient outcomes (Table 2), five
(42%) were from the USA, three (25%) were from Canada, two (17%)
were from Australia, and there was one study each from Iran and
Taiwan. Studies describing urban-rural differences in patient outcomes
used either ecological (n = 5) and cohort (n = 7) study designs. Across
both review objectives, urban-rural status was predominantly defined
by the location of the treating hospital, with a minority of studies using
patients' residential addresses, or the catchment areas of emergency
services.
Fig. 1. Study flow diagram.
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3.2. Methodological quality
The median study quality score was 6.5/9 (IQR 4.75–7) for studies
addressing care, and 7/9 (IQR 7–8) for studies addressing outcomes.
Most studies used either registry data or trained abstractors to review
medical records, and, as such, generally scored well in the ‘selection’
and ‘outcome’ domains. A number of studies had reduced quality scores
due to an absence of sample size calculations and undisclosed defini-
tions of urban-rural status.
3.3. Urban-rural differences in acute stroke care
Table 3 summarises the urban-rural differences in care found within
the included studies; the following narrative synthesis describes dif-
ferences found within specific domains of acute stroke care.
3.3.1. Pre-hospital care
The provision of pre-hospital care was addressed by six studies
[24–29]. There were eight instances in which no association was found
between hospital location and patients' likelihood of receiving certain
interventions [24,25]. Five studies [25–29] reported one instance each
where urban hospitals had higher levels of adherence on measures of
ambulance transport and pre-hospital assessment.
3.3.2. Hyperacute care
Nine studies [12,26–28,30–34] investigated urban-rural disparities
in the provision of hyperacute therapies, of which thrombolysis was by
far the most commonly mentioned. Each of these studies contained
some evidence to suggest that rural patients either i) experienced
greater delays when being administered thrombolysis, or ii) were less
likely to receive thrombolysis. Notwithstanding this, there were in-
stances where rural hospitals provided hyperacute care that was com-
mensurate with that of urban hospitals [12,26,27,32]. Studies that
employed multi-level analyses to control for hospital characteristics
produced conflicting findings [12,30,31]. Seabury and colleagues [33]
also found that disparities in rates of thrombolysis administration be-
tween metropolitan and non-metropolitan settings were markedly re-
duced in cases where both sites were equipped with certified stroke
centres.
3.3.3. Investigations
Five studies [12,25,27,28,32] examined variation in hospitals' use
of investigations for acute stroke, which centred on the use of medical
imaging and blood tests. Around half of the urban-rural comparisons
made suggested that rural patients received fewer investigations than
their urban counterparts, while the remaining comparisons found no
difference.
3.3.4. General acute care
Seven studies [12,27,28,32,35–37] discussed urban-rural differ-
ences in ‘general’ aspects of acute hospital care, covering dysphagia
screening, acute stroke unit care, and post-discharge planning, among
other factors. A majority (76%) of comparisons made suggested that
rural hospitals had a lower adherence to the care processes measured.
Phipps et al. [12] noted that there were no significant urban-rural
differences with control for hospital characteristics. Additionally,
Prabhakaran et al. [37] noted that rural patients were more likely to
have ‘comfort measures only’ care enacted by their second day of
hospitalisation, after controlling for potential confounders.
3.3.5. Secondary prevention
Five studies [12,27,28,32,33] addressed secondary stroke preven-
tion, which primarily related to the provision of medications (e.g. anti-
thrombotics, anti-hypertensives). There were, however, instances
where smoking cessation advice [12] and stroke education [33] were
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Table 3
Findings of studies examining urban-rural differences in stroke patient care.
Study Urban-rural differences in care Postulated causes of disparities
35 • Patients in non-metropolitan areas were less likely to be treated in a Stroke Care
Unit (77% vs 3%, p < .05).
• Metropolitan hospitals were more likely than regional hospitals to be equipped
with a SCU
29 • Rural patients were less likely than those in urban areas to be transported to
hospital via ambulance (OR = 0.85, 95% CI 0.74–0.97, p < .05).
• Findings adjusted for age, race, comorbidities, insurance status, arrival time,
stroke severity, US Census region, and hospital characteristics.
• Disparities in the use of ambulance transport may be attributed to patient
factors (e.g. fears of medical bills).
• Disparities may also be due to differences in stroke education (i.e. symptom
recognition).
30 • Patients treated in urban hospitals were more likely to receive thrombolysis
(OR = 2.11, 95% CI 1.97–2.27, p < .0001). Findings controlled for year,
patient age, race, sex, insurance status, US census region, and hospital
characteristics.
• The proportion of urban patients receiving thrombolysis quadrupled during the
study period (range 1.17%–4.87%) compared to rural hospitals (range
0.87%–1.59%).
• Hospitals located in rural areas are less likely to be certified as Primary Stroke
Centers (PSCs)
• Many rural hospitals cannot afford the accreditation process associated with
becoming a PSC.
• There may be fewer neurologists operating in rural areas.• Rural areas may have lower rates of preventative health care, making
contraindication for thrombolysis more likely.
• Patients in rural areas may have relatively less knowledge of stroke symptoms,
causing delays to the treatment process.
• Rural patients may also need to travel further to the nearest hospital, causing
delays to the treatment process.
24 • Univariate analysis revealed no association between patients' ambulance
transport and their urban/rural status (OR = 1.02, 95% CI = 0.59–1.77).
• No association was found between patients' ambulance transport and their
urban/rural status after adjusting for confounders (OR = 1.36, 95%
CI = 0.82–2.24).
• No explanation offered
25 • Urban patients were more likely to be assessed with Cincinnati Prehospital
Stroke Scale (CPSS) (70.3% vs 31.8%, p < .05).
• No significant between group differences were found in the remaining
indicators.
• High compliance rates observed in both urban and rural settings may be
partially attributed to the fact that both regions had developed similar acute
stroke protocols and prehospital algorithms with the accepting stroke centre.
• Lower rates of CPSS use in rural settings may be attributed to regional
differences in documentation.
26 • Rates of in-hospital thrombolysis were significantly higher in the urban network
(26.9% vs 15.4%, p < .001).
• Median prehospital delays were longer in the urban network (88 mins vs 65
mins, p < .001), while in-hospital delays were longer in the rural network (18
mins vs 40 mins, p < .001).
• There were no significant differences in the overall proportion of individuals
receiving thrombolysis in each network
• There were no significant differences between regions with respect to overall
delays.
• Rates of in-hospital thrombolysis were higher in the urban network, as this
hospital only received ambulance transfers for patients who were potential
thrombolysis candidates. In contrast, patients in the rural network were
transferred to nearby hospitals regardless of their eligibility for thrombolysis.
• Differences in pre-hospital delays were attributed to relatively short travel times
inside the rural network.
• Small hospitals in the rural network may have been less accustomed to providing
thrombolysis than the urban hospital.
31 • Hospitals in areas with a population density exceeding 500 persons per square
mile administered thrombolysis at three times the rate of hospitals in areas with
a population density of < 50 persons/sq. mile (2.7% vs 0.9%).
• Population density was significantly associated with thrombolysis rates after
adjustment for hospital size, census region.
• Rural hospitals may see few eligible thrombolysis cases annually, making it
difficult to maintain treatment protocols.
• Patients initially treated in rural hospitals may have been transferred to larger
centres in order to receive thrombolysis.
• The study's age group of 65 and over is likely to have excluded some patients
who received thrombolysis.
27 • Compared with urban hospitals, rural hospitals scored significantly lower on all
but five of the care processes measured.
• No significant regional differences were found with respect to patients' onset to
presentation times, thrombolysis rates, and secondary prevention medications
(i.e. statins, antiplatelets, anticoagulants).
• Rural hospitals performed a greater proportion of telestroke consults.
• Findings may reflect the limited resources in smaller or remote settings. This is
supported by the fact that interventions not requiring additional resources
(e.g. secondary prevention medications) were comparable in both settings.
• Comparable rates of thrombolysis administration may be partially explained by
efforts made during the study period to improve i) the transportation of patients
to regional stroke centres and ii) the use of telemedicine for thrombolysis.
38 • Rural patients received more direct OT sessions; however, these sessions were
shorter than that of metropolitan patients.
• Metropolitan patients received more indirect OT sessions, but there were no
regional differences in session duration.
• Rural patients received significantly more direct physiotherapy sessions, but
fewer indirect physiotherapy sessions.
• The referral process for allied health interventions may be a barrier to timely
care (however, this issue was not necessarily worse in either metropolitan or
rural hospitals).
36 • Compared with urban patients, those in nonurban areas were less likely to be
evaluated at a PSC (9.1% vs 23.9%, p < .001).
• This disparity remained after adjusting for patient demographics and
comorbidities (OR = 0.39, 95% CI 0.22–0.67).
• Nonurban patients' geographic access to PSC care is likely to have been lower
than that of urban patients. ‘Geographic access’ incorporates the time,
distance, and cost associated with seeking a given treatment.
12 • In univariate analyses, rural patients received significantly fewer of the
following interventions: DVT prophylaxis, secondary prevention medications,
NIHSS assessments, and smoking cessation counselling.
• Rural patients had more assessments for fall risks and rehabilitation, and were
more likely to be given stroke education.
• No regional differences were found with respect to thrombolysis rates, atrial
fibrillation management, dysphagia screening, early ambulation, and
assessments for the risk of pressure ulcers.
• After adjustment for patient and facility level characteristics, rural patients were
significantly less likely to receive DVT prophylaxis (OR = 0.35, 95% CI
0.15–0.81), but more likely to receive rehabilitation assessments (OR = 2.8,
95% CI 1.3–5.9).
• There were no significant regional differences among the remaining care
processes.
• Similarities in the quality of care delivered across settings may be partially
explained by the fact that the Veteran's Affairs health care system is a national
organization, which implements system-wide quality improvement initiatives.
• Rural patients may have been relatively more complex, therefore having a
greater need for rehabilitation services.
(continued on next page)
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association, or a slight positive association, found between rural loca-
tion and the provision of secondary prevention care. The remaining
comparisons suggested that patients treated in rural hospitals received
relatively fewer interventions aimed at reducing the risk of secondary
stroke.
3.3.6. Allied health
Six studies [12,27,28,32,33,38] examined differences in the provi-
sion of allied health care across urban and rural settings. Studies re-
ferred to care provided by dietitians, occupational therapists, psychol-
ogists, physiotherapists, speech pathologists, and social workers,
focussing on patients' initial assessments and their ongoing rehabilita-
tion care. Sixty percent of comparisons made suggested that rural pa-
tients received comparatively less allied health care than their urban
counterparts. Three studies [12,28,38] identified seven instances in
which rural patients received a greater amount of allied health care
than urban patients. Three studies [12,28,32] identified nine cases in
which urban and rural hospitals provided a commensurate level of al-
lied health care.
3.4. Urban-rural differences in stroke patient outcomes
Table 4 summarises the urban-rural differences in patient outcomes
found within the included studies; the following synthesis describes
variations found within specific outcome measures.
3.4.1. Mortality
Ten studies measured risk-adjusted mortality rates, of which in-
hospital mortality was the most commonly used measure, appearing on
10 occasions within six studies [35,39–43]. A majority (70%) of these
comparisons found no association between hospital location and a pa-
tient's likelihood of in-hospital mortality. The remaining three com-
parisons each found evidence of higher rates of in-hospital mortality
within rural hospitals [35,42,43]. Several studies examined mortality in
the post-discharge period; within these studies, there were three in-
stances [27,44] in which no significant differences were found between
urban and rural settings. Lastly, the studies by Lichtman et al. [45] and
Ido et al. [46] found evidence of higher mortality rates in rural settings
at 30 days and 12 months post-discharge, respectively.
3.4.2. Readmission
Three studies [44,45,47] analysed urban-rural differences in read-
mission rates within one month of discharge, all of which found no
association between hospital location and a patient's risk of read-
mission.
3.4.3. Other outcome measures
The remaining outcome measures related to patients' functional
independence at discharge, their discharge destination, and the pre-
sence of severe complications during their admission. Cadilhac et al.
[35] identified four instances in which rural patients were more likely
than their urban counterparts to be functionally dependent at dis-
charge. The same paper produced conflicting findings with respect to
patients' risk of experiencing severe complications during their admis-
sion. Lastly, Davis [48] reported that urban patients were less likely
than rural patients to be discharged to assisted living facilities, but more
likely to be discharged to inpatient rehabilitation facilities (deemed to
be the least desirable outcome).
4. Discussion
We aimed to identify urban-rural differences in the care and out-
comes of acute stroke patients. Most studies addressing acute stroke
care provided some evidence to suggest that when compared to urban
patients, those in rural areas had comparatively less access to evidence-
based acute stroke care. In contrast, studies describing urban-rural
differences in patient outcomes were inconsistent in their findings.
The most frequently mentioned disparities in care related to the
provision of thrombolysis [12,26–28,30,31,33,34]. Gonzales et al. [30]
summarised the potential causes of these disparities, citing barriers
relating to structure (i.e. provider, facility, and organizational char-
acteristics, ability to access care), processes (i.e. diagnosis, treatment)
and patient attributes (i.e. thrombolysis eligibility, disease severity).
Leira et al. [10] noted in an earlier review that rural hospitals may also
Table 3 (continued)
Study Urban-rural differences in care Postulated causes of disparities
• After controlling for patient and facility level characteristics, patients in rural
hospitals were more likely than those in urban hospitals to receive early ‘comfort
measures only’ care (OR = 1.18, 95% CI 1.05–1.31, p = .004).
32 • Metropolitan patients received a greater proportion of swallowing and speech
pathology assessments, and DVT prophylaxis interventions.
• Regional patients were less likely to have their lipid and glucose levels tested, or
to undergo an echocardiogram.
• No differences were found in rates of hyperacute aspirin therapy, or in
assessments by social workers, physiotherapists, or occupational therapists.
• No differences were found in rates of antithrombotic therapy, or in the
management of hypertension, dyslipidaemia, or atrial fibrillation.
• Variation in staffing levels, the lack of stroke care protocols, and a lack of local
resources or equipment.
33 • Patients in non-metropolitan hospitals were less likely to receive each of the
eight care processes measured.
• Among non-certified stroke centres, 38.3% of eligible patients arriving with two
hours of symptom onset in non-metropolitan areas were given thrombolysis,
while the same figure for large metropolitan hospitals was 73%. The divide
between metropolitan and non-metropolitan certified stroke centres was
considerably smaller (83.2% vs 86.2%).
• The lack of protocols for acute stroke care• Deficits in access to neurological services (measured by the number of
neurologists per capita).
• Absence of decision support systems (e.g. telemedicine).
34 • The proportion of urban hospitals which had administered thrombolysis during
the preceding 12 months was significantly higher than that of rural hospitals
(88% vs 53%, p < .001)
• Comparatively less access to stroke personnel and written stroke protocols.
Both factors affect hospitals' ability to “drip and ship” patients (i.e. transfer
patients to larger hospitals after they have been administered thrombolysis).
28 • Regional hospitals were found to have relatively lower compliance in all but nine
care process measures.
• No between group differences were found in the proportion of patients involved
in the development of their care plans, time taken for social worker/dietitian/
physiotherapy assessments, and anticoagulant therapy for atrial fibrillation.
• Regional hospitals showed higher rates of adherence to the following care
process measures: lipid-lowering therapy, stroke education, rehabilitation
assessments, and assessment within emergency departments.
• Presentation of findings only - no explanations offered
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37 • The size and location of the hospital, and its annual volume of stroke patients.• Variations in patient and/or physician attitudes towards end-of-life decisions
37
Table 4
Findings of studies examining urban-rural differences in stroke patient outcomes.
Study Covariates Urban-rural differences in outcomes Postulated causes of disparities
41 • Age, sex, SES • There was no significant association between
patients' rural residence and their odds of in-
hospital mortality (OR = 1.17, 95% CI
0.99–1.39, p = .065)
• None stated
35 †Age, sex, country of birth, hypertension, hyperlipidaemia,
ability to walk on admission and incontinence within 72 h of
presentation.
‡Stroke unit care, age, sex, Australian born, living alone, history
of hypertension, diabetes or hyperlipidaemia, walk on admission
and incontinence within 72 h.
*Clustering of patients in hospitals, stroke unit care, age, sex,
Australian-born, living alone, history of hypertension, diabetes or
hyperlipidaemia, walking ability on admission and incontinence
within first 72 h.
†Rural patients' in-hospital mortality was higher
(OR = 1.46; 95% CI, 1.03–2.05).
†Rural patients were more likely to be dependent
following their discharge (OR, 1.75; 95% CI,
1.35–2.28).
†Rural patients were more likely to experience a
severe complication during their admission (OR,
1.66; 95% CI, 1.16–2.38).
‡Rural patients were less likely to be independent
following their discharge from hospital
(OR = 0.55, 95% CI 0.32–0.96)
‡Rural patients were more likely to be dependent
following their discharge from hospital
(OR = 1.82, 95% CI 1.23–2.70)
‡No between group differences were found in the
odds of in-hospital mortality (OR = 1.00, 95% CI
0.62–1.61) or severe complications (OR = 1.23,
95% CI 0.74–2.05)
*Rural patients were more likely to be dependent
following their discharge from hospital
(OR = 1.82, 95% CI 1.03–3.19)
*No between group differences were found in the
odds of in-hospital mortality (OR = 1.00, 95% CI
0.53–1.87) or severe complications (OR = 1.23,
95% CI 0.61–2.49).
• Lower levels of dependency found among
patients treated in metropolitan hospitals
may be because the rural SCU surveyed had
only been recently established.
• Rural patients generally had fewer
comorbidities, and were more likely to be able
to walk at admission.
• Rural patients were more likely to have been
born in Australia (which is understood to bias
such patients towards improved outcomes).
• Other aspects of care in rural hospitals may be
responsible for the observed disparities in
outcomes.
48 • Age, stroke subtype, insurance status, race • Urban patients were less likely to be
discharged to an assisted living facility
(OR = 0.68, 95% CI 0.66–0.71, p < .001)
• Urban patients were more likely require care
at an inpatient rehabilitation facility (deemed
to be the most severe outcome) (OR = 1.18,
95% CI 1.13–1.24, p < .001)
• Rural patients may be more likely to require
assisted living facilities, as their strokes were
more severe.
• Rural patients may be less likely to be
discharged to inpatient rehabilitation facilities
(deemed to be the most severe outcome)
because such facilities are not readily available
in rural areas.
42 • Age, sex, heart failure or pulmonary oedema, cancer, renal
failure, ischaemic heart disease.
• During each of the five years studied, rates of
risk-adjusted 30-day in-hospital mortality
were significantly higher in rural than urban
hospitals.
• Rates of in-hospital mortality in rural hospitals
were also higher than the national average for
each year of the study period except one.
Several factors not measured as part of the study:
• The presence or absence of an organized stroke
team
• Geographic factors (e.g. patient proximity to
EDs)
• Inter-facility transfer capability• Support from academic centres• Rural patient characteristics.
43 • Age, sex, triage score, Charlson Comorbidity Index score. • The odds of in-hospital mortality for ischaemic
stroke patients admitted to major medical
centres were 0.4 times that of their
counterparts in regional hospitals.
• No regional differences were noted in terms of
haemorrhagic stroke outcomes.
• Major medical centres may have more
“manpower” to allocate.
• Variation in outcomes for haemorrhagic stroke
is likely to reflect underlying disease severity,
as opposed to hospitals' acute interventions.
39 • Age, sex, race, insurance status, hospital trauma centre
designation, patient intubation or mechanical ventilation,
hospital do-not-resuscitate rate, hospital craniotomy rate,
hospital intracerebral haemorrhage volume, teaching
hospital status.
• No significant association was found between
patients' treatment in a rural hospital and their
odds of in-hospital mortality (OR = 0.81, 95%
CI 0.60–1.08, p = .16)
• None stated
46 • Age, sex, race, insurance status, length of stay in hospital,
hospital size, hospital participation in registry (y/n), calendar
year.
• Patients treated in non-metropolitan hospitals
were more likely to have died within 1 year of
their admission for stroke (RR = 1.11, 95% CI
1.03–1.21, p = .009).
• None stated
47 • Age, sex, premorbid independence, diabetes, heart disease,
arm weakness, impaired speech, walking ability at
admission, incontinence within 72 h of admission, brain
imaging in first 24 h, provision of a discharge strategy,
neurologist management, and any complications.
• No significant association was found between
patients' treatment in a rural hospital and their
odds of readmission within 28 days
(OR = 1.21, 95% CI 0.73–2.00, p = .46)
• None stated
27 • Age, sex, income, smoking history, diabetes, hypertension,
hyperlipidaemia, prior stroke, atrial fibrillation, coronary
artery disease, peripheral vascular disease, dementia, stroke
severity and subtype.
• There was a non-significant trend towards
higher 30-day mortality in rural compared to
urban patients (HR = 1.14, 95% CI 0.99–1.32)
• No association was found between patients'
rural residence and their combined risk of 30-
day mortality and disability at discharge
(HR = 1.03, 0.92–1.16).
• None stated
(continued on next page)
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experience difficulty in adapting and implementing models of care for
thrombolysis, which are often developed in well-resourced urban hos-
pitals. That being said, three recent studies [12,26,27] all found little
overall effect of urban-rural status on thrombolysis administration
rates. Each of these hospital networks had previously been subject to
quality improvement initiatives, and two [26,27] had made extensive
use of telemedicine. This suggests that with adequate investment, rural
networks can administer thrombolysis at rates comparable to urban
hospitals. Future researchers are encouraged to describe their experi-
ences of adapting models of care for use in rural settings, as done by
Slivinski et al. [49].
The greatest similarities in acute stroke care were found within the
domain of secondary prevention, which Koifman et al. [27] attributed
to the fact that such interventions do not typically require any addi-
tional resourcing. The issue of resourcing constraints in rural areas was
mentioned in several studies, often with reference to stroke units 27, 30,
35 and staffing levels [27,30,32–34]. An absence of care protocols in
rural areas was another often cited cause of care disparities [32–34],
with two authors [26,31] speculating that rural hospitals' low patient
volumes could make it untenable to maintain such protocols. Taken
together, these findings may be indicative of a threshold effect of pa-
tient volume on stroke care quality, a phenomenon which has been
described previously [50].
Of the ‘care’ studies which were deemed to be of high methodolo-
gical quality, all but two were conducted in the US, which operates a
‘user pays’ healthcare system. Accordingly, patients' insurance status,
and their perceptions of the financial costs associated with seeking
healthcare were noted to have influenced the findings of several studies
[24,29,36,37]. The extent of acute stroke care provided to American
patients also appears to be contingent on the certification status of the
admitting hospital. Indeed, hospital certification (e.g. as a Primary or
Comprehensive Stroke Center) has been described as an essential step
towards improving the quality of stroke care [51]. The cost of certifi-
cation is borne by hospitals individually and, as Gonzales et al. [30]
note, factors including hospital size and casemix can make this process
financially unviable for smaller hospitals. For these reasons, the find-
ings of, and conclusions drawn by, US-based studies may not be gen-
eralizable to universal healthcare contexts.
As mentioned above, the findings of studies reporting urban-rural
differences in patient outcomes were largely inconsistent. There were,
however, some patterns to emerge from the data. Several studies
[35,39,40,47] found no significant association between urban/rural
status and patient outcomes after adjusting for both patient (e.g. patient
age) and facility-level (e.g. stroke patient volume) characteristics. Of
the four studies which did report higher rates of mortality in rural
areas, three [42,43,45] did not adjust for patients' baseline stroke se-
verity. Given that stroke severity is a strong predictor of stroke patients'
30-day outcomes [52], the presence of residual confounding in these
studies cannot be discounted. Future research utilising multi-level
modelling to adjust for patient and facility-level factors is needed to
reveal more about the nature of urban-rural differences in stroke pa-
tient outcomes.
Only half of the studies reporting outcomes explicitly measured the
impact of urban-rural status on patient outcomes [27,35,42–45] and
only two studies [27,35] measured both care and outcomes. This pro-
vides scope for future studies to directly address the issue of urban-rural
disparities in stroke, whilst incorporating measures of care and out-
comes. Such methods are available, and have previously been used to
describe disparities in care and outcomes between in-hospital vs com-
munity onset stroke [53] and with socioeconomic status [54]. It is
conceivable that with an established link between urban-rural differ-
ences in care and corresponding differences in patient outcomes, pol-
icymakers would be compelled to address the issue.
Our review contains several limitations. Firstly, it is likely that not
all of the care disparities reported in this review represent clinically
relevant differences in care quality. Secondly, whilst most of the care
processes mentioned in this review have demonstrable links with pa-
tient outcomes [55], others may not, and could therefore be considered
to lack validity as process indicators [56]. It is plausible, however, that
such care processes are a marker of overall care quality. Thirdly, we
cannot discount the influence of publication bias in this review. We
attempted to counter this by including unpublished findings [48];
however, we also recognise that emphasising urban-rural differences in
care quality and outcomes has long been the primary concern of rural
health researchers [57]. Lastly, and as mentioned above, many of the
review's findings were indirect; this was particularly the case where
outcomes were concerned.
Despite these limitations, this review makes several meaningful
contributions. Our review is, to the best of the authors' knowledge, the
first to address the topic of urban-rural differences in stroke care and
outcomes in a systematic manner. We note that whilst an urban-rural
divide in care quality still exists, these differences are not necessarily
pervasive, as has been suggested previously [10]. We also emphasise
the importance of considering health system context when interpreting
studies of care disparities. Lastly, we note that much of the available
data surrounding urban-rural differences in stroke patient outcomes
Table 4 (continued)
Study Covariates Urban-rural differences in outcomes Postulated causes of disparities
• Age, sex, cardiovascular disease/stroke history (i.e.
congestive heart failure, acute myocardial infarction,
unstable angina, chronic atherosclerosis,
cardiopulmonary–respiratory failure, peripheral vascular
disease, cerebrovascular disease), and 20 other comorbid
illnesses.
• The risk standardised 30-day mortality ratio of
CAHs was significantly higher than that of
non-CAHs (11.9% ± 1.4% vs
10.9% ± 1.7%; p < .001).
• No differences were found between CAHs and
non-CAHs with respect to 30-day readmission
rates.
• Stroke patient volume; the relatively low
number of cases seen by CAHs may be
insufficient for staff to maintain their
skillsets.
• Patients treated in CAHs potentially have
longer travel times, and hence may arrive at
CAHs in a more deteriorated condition.
• Rural patients may have less knowledge of
stroke warning signs.
• Rural patients may decline to be transferred to
larger urban hospitals.
40 • Age, sex, Charlson Comorbidity Index score, facility type,
most responsible physician, ICU admission, neighbourhood
income, weekend admission, hospital stroke patient volume.
• There were non-significant associations
between rural hospitals and patients' odds of
7-day in-hospital mortality (OR = 0.97, 95%
CI 0.85–1.12) and mortality at discharge
(OR = 1.12, 95% CI 0.99–1.25)
• None stated
44 • Age, sex, race, comorbid illnesses (atrial fibrillation, previous
ischaemic stroke/TIA, previous myocardial infarction,
diabetes, hypertension, smoking) and hospital characteristics
(e.g. patient volume, staffing levels, and teaching hospital
status, among other factors).
• No significant association was found between
hospitals' rural location and their rates of 30-
day mortality or 30-day readmission.
• Between region differences in stroke severity
(not measured)
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available to researchers are, for the most part, not being utilised to
address differences in patient outcomes. It is hoped that future re-
searchers can employ these resources to highlight the societal burden
associated with urban-rural disparities in stroke care, and in doing so,
prompt policymakers to address the issue.
M. Dwyer et al.
originates from studies with varying objectives, highlighting the need 
for future studies to address the issue directly.
In conclusion, interventions for acute stroke are differentially dis-
tributed between urban and rural settings, and this is particularly the
case where thrombolysis is concerned. It is reasonable to surmise that 
this is affecting patient outcomes, and yet, the data and methodology
Journal of the Neurological Sciences 397 (2019) 63–74
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3. CHAPTER THREE: Regional differences in access to acute ischaemic 
stroke care and patient outcomes 
 
The previous chapter provided a summary of existing body of literature describing urban-
rural differences in acute stroke care and patient outcomes. Recognising the limitations of the 
existing literature, the current chapter seeks to describe the regional differences in acute 
ischaemic stroke care and outcomes within the Australian state of Tasmania. 
 
This work was published in Internal Medicine Journal, the official journal of the Adult 
Medicine Division of The Royal Australasian College of Physicians (RACP). 
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Regional differences in access to acute ischaemic stroke care and patient 
outcomes 
In spite of falling incidence rates in recent years (5), stroke continues to place a large burden 
on society. Stroke is the third leading cause of death in Australia, accounting for around 7% 
of all deaths in the year 2017 (104). The reduction of Australia’s stroke burden has been 
attributed to, among other factors, advances made in the field of acute stroke care (5). Chiefly 
among these are the advent of acute stroke unit (ASU) care (60), and the increasing use of 
thrombolysis for ischaemic stroke (72). Unfortunately, the benefits of these interventions 
have not been uniformly distributed throughout the population. Several reports commissioned 
by Australia’s Stroke Foundation (3, 62, 105) have highlighted that, when compared to 
individuals in urban areas, those in rural areas have poorer access to acute stroke care. Whilst 
these reports employed large samples from a broad range of hospitals, they have tended not to 
provide risk-adjusted data on patient outcomes.    
At the same time, other Australian studies which have addressed regional differences 
in acute stroke outcomes (94, 96) have had some methodological limitations. Read and 
Levy’s study (94) reported several between-region differences in care, but did not apply any 
risk adjustment to its outcome measures, and hence may have been vulnerable to residual 
confounding. The study by Cadilhac et al. (96) accounted for a host of potential confounders; 
however, its utility was somewhat limited by only measuring in-hospital mortality. For 
instance, in-hospital mortality figures may be influenced by patients being transferred to 
separate facilities for palliation (106, 107). Given that the overall burden of stroke is known 
to be significantly higher in rural areas (3), there is reason to investigate whether the care that 
stroke patients receive in rural settings, and the associated outcomes, are contributing to this 
apparent urban-rural divide. Accordingly, the aim of this study was to describe the regional 
differences in acute ischaemic stroke care and outcomes within the Australian state of 
Tasmania. 
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Materials and Methods 
We conducted a retrospective study of the management and outcomes of patients admitted 
with acute ischaemic stroke to Tasmania’s four major public hospitals.  
Setting 
Tasmania is Australia’s only island state, and as of June 2018, had an estimated population of 
528,000 (48). The majority of the state’s population is concentrated in three regions: Hobart, 
Launceston, and the North West Coast, primarily in the cities of Devonport and Burnie. This 
study was limited to four hospitals, which are regarded by the Tasmanian Department of 
Health as being the state’s only major public hospitals (108). Other, smaller sites were 
omitted from the analyses, as stroke patients who present to these sites are invariably 
transferred to one of the major public hospitals. The Royal Hobart Hospital (RHH) is the 
state’s largest centre, serving a population of approximately 250,000 and with a maximum 
capacity of 470 beds (109). The Launceston General Hospital (LGH) is a 300-bed centre 
serving much of the state’s north and north east (110). Both the LGH and RHH are equipped 
with specialist staff in neurology; however, acute stroke care at the LGH is managed by the 
hospital’s General Medical team. The RHH has offered endovascular clot retrieval to eligible 
patients since 2016; however, this is not a 24-hour service.  
The Mersey Community Hospital (MCH) and North West Regional Hospital 
(NWRH) are located approximately 60 kilometres apart in the state’s north west, and have 
capacities of 100 and 160 beds, respectively (111). The catchment area of these two hospitals 
spans the entire north west of Tasmania, including King Island (111). In Australia, regions 
are classified in terms of their remoteness using the Accessibility/Remoteness Index for 
Australia 2011 (ARIA+) system, which groups areas based on their access to services (112). 
Under this system the LGH and RHH are situated in ‘inner regional’ areas, while the MCH 
and NWRH are in ‘outer regional’ areas. For the purpose of the current study, the RHH and 
LGH were classified as ‘urban’ hospitals, and the MCH and NWRH as ‘rural’ hospitals.  
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Sample  
This study included patients admitted to one of the four major public hospitals with a 
principal diagnosis of acute ischaemic stroke (ICD-10-AM codes I63.x, I64) between 1st 
January 2015 to 8th March 2017. We then excluded those cases which, despite being coded 
as ‘acute ischaemic stroke’, were found to be related to other neurological complaints (e.g. 
Bell’s palsy). We also excluded all non-acute episodes of care (e.g. admissions for palliation, 
rehabilitation), in-hospital strokes, and episodes of care lasting less than 24 hours. Patients 
who had been transferred between the four hospitals were also excluded, to avoid attributing 
care and outcomes to a different hospital. We aimed to recruit a convenience sample of 100 
cases from each of the four hospitals, giving 200 cases per sub-group (urban/rural). Screening 
cases by their ICD codes yielded the following sub-samples (RHH = 619, LGH = 390, MCH 
= 112, NWRH = 196). Cases were then randomly drawn without replacement, using the 
'Sample' package in R (113) from these sub-samples until there were 100 eligible cases each 
from the RHH, LGH and NWRH (i.e. 300 in total from these hospitals) which met the 
inclusion criteria. A total of 95 cases were included for the MCH, which represented all 
eligible cases during the study period.  
Outcome Variables 
This study’s key variables were care processes and outcome measures. The care processes of 
interest were a sub-set of 13 indicators from the Acute Stroke Clinical Care Standard (65). 
This standard was developed by the Australian Commission on Safety and Quality in Health 
Care, and covers the recognition of stroke, rapid assessment, early management and early 
initiation of rehabilitation care. The researchers adhered to the Clinical Care Standard’s 
Indicator Specification document (114), which stipulates the inclusion and exclusion criteria 
to be used for each indicator. For example, individuals with documented hypotension are 
contraindicated for antihypertensive medication, and would therefore be excluded from this 
indicator. Six of the care processes featured in the Clinical Care Standard were excluded 
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from the audit. Indicators 1A and 1B, which relate to the transport and assessment of stroke 
patients by ambulance crews, were omitted due to the absence of a reliable operational 
definition for these variables. Indicator 5A was excluded as it specifically relates to 
haemorrhagic stroke patients. Indicators 6A, 6B, and 7A relate to ongoing rehabilitation care, 
and were not collected as we focussed exclusively on episodes of acute care. In addition, two 
indicators relating to the management of dysphagia, obtained from the National Stroke Data 
Dictionary (115), were added to the analyses because dysphagia management is regarded as 
an important component of acute stroke care (116). Patient outcome measures were assessed 
using 30-day mortality and discharge destination (i.e. usual place of residence vs other). 
Data Collection 
Data from the Admitted Patient Care National Minimum Data Set (APC NMDS) (117) were 
obtained via the Tasmanian Health Service (THS). The APC NMDS provides the timestamps 
of each admission, along with patient demographics (i.e. age, sex) and discharge destination. 
Admission details were then used to access patients’ digital medical records. National 
Institutes of Health Stroke Scale (NIHSS) (118) scores were retrospectively calculated for 
each case using the algorithm described by Williams et al. (119). NIHSS scores are routinely 
used to assess the neurological impairment resulting from stroke, and are also a strong 
predictor of post-stroke outcomes (120). Mortality data were obtained from the Tasmanian 
Department of Health, which routinely links patients’ unique reference numbers to the 
National Death Index (88).         
    Data relating to care process were extracted from medical records and entered into a 
database using standardised worksheets (121). Error checks were incorporated into the tool to 
prevent the collection of illogical data. In each instance where a patient was ineligible for a 
given care process (e.g. due to contraindication), this was checked by a second researcher. 
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Two abstractors completed half of the MCH and NWRH cases each, while all of the LGH 
and RHH cases were abstracted by the main researcher (MD). Data abstracted from medical 
records was reviewed for completeness by MD; missing data were added in a second round 
of data abstraction.    
Data Analysis 
In order to test for regional differences in patient characteristics, categorical variables were 
compared between regions using chi-square tests, while mean ages and median length of stay 
(LOS) were compared using an independent samples t-test and a Mann-Whitney U-test, 
respectively. Care processes were expressed as the proportion of eligible patients from each 
region who received each form of care and analysed using Fisher’s Exact test. LOS was 
calculated by subtracting each case’s discharge timestamp from the timestamp of the patient’s 
admission to hospital (i.e. as opposed to their presentation to an ED). 
Logistic regression models were used to quantify urban-rural differences in 30-day 
mortality and patient discharge destination. Outcome measures used individual-level data but 
were analysed at the level of the region (i.e. urban or rural). Hospital variation was accounted 
for by using a cluster variable for each hospital in the models. We adjusted for patient 
characteristics which may have accounted for regional differences in outcomes; these factors 
were purposefully selected because they were associated with the outcome and the exposure. 
NIHSS scores were dichotomised into Mild (NIHSS ≤7) and Moderate/Severe (NIHSS 8+) 
for the purpose of reporting and analyses, as has been done previously (75, 122, 123). A 
forward stepwise procedure was then used to determine the final regression model that 
included the review of nested models and analysis of likelihood ratio tests. Data were 
analysed using R (113). Ethical approval to conduct this study was obtained from the Human 
Research Ethics Committee of Tasmania (application H0016053).  
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Results 
The study sample consisted of 395 patients, of whom 195 (49%) were admitted to rural 
hospitals. Baseline characteristics of study patients are shown in Table 1. Patients admitted to 
rural hospitals were more likely to have a comorbid diagnosis of atrial fibrillation (AF; 27.2% 
vs 16.5%, p = .01) but less likely to be tobacco users (8.7% vs 15.5%, p = .045). There were 
no statistically significant differences between regions on any of the other measures. 
Table 1. Patient Characteristics 
  Overall Urban (n=200) Rural (n=195) P value 
  % n (%) n (%)  
Mean Age (SD), years 71.4 70.9 (13.9) 71.9 (13.2) .45 
Female 39 82 (41) 72 (36.9) .47 
Stroke Risk Factors     
 Atrial Fibrillation 21.8 33 (16.5) 53 (27.2) .01* 
 Ischaemic Heart Disease 5 10 (5) 10 (5.1) 1.00 
 Diabetes 23.8 51 (25.5) 43 (22.1) .49 
 Hypertension 45.8 83 (41.5) 98 (50.2) .10 
 Tobacco Use 12.1 31 (15.5) 17 (8.7) .05* 
 Previous Stroke 9.4 18 (9) 19 (9.7) .80 
rNIHSS Score     
 Mild (NIHSS ≤7) 82.8 161 (80.5) 166 (85.1) .28 
 Moderate/Severe (NIHSS 8+) 17.2 39 (19.5) 29 (14.9) - 
Discharged Home 50.1 94 (47) 104 (53.3) .21 
In-hospital Mortality 9.1 16 (8) 20 (10.3) .55 
30-day Mortality 10.6 22 (11) 20 (10.3) .94 
Median LOS1 (IQR), days 5.9 (3.0-9.8) 6.0 (3.1-9.4) 5.9 (3.0-9.8) 1.00 
 
1LOS = length of stay 
*p<.05 
 
Data collected in relation to care processes are presented in Table 2 (Appendix); national 
average figures obtained from the Stroke Foundation’s 2017 National Stroke Audit Acute 
Services Report (62) and the Australian Stroke Clinical Registry (AuSCR), where applicable 
(86). No patients admitted to the state’s rural hospitals received thrombolysis, nor did any 
receive treatment in an ASU. Patients admitted to rural hospitals were, overall, less likely to 
receive risk factor modification advice and secondary prevention medication prescription on 
discharge. These differences were most pronounced in the number of patients prescribed oral 
anticoagulants, when not contraindicated, for AF (65.3% vs 96.9%, p<.001), and the number 
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of individuals given documented advice about risk factor modification prior to discharge 
(45.3% vs 70.2%, p<.05). Patients admitted to rural hospitals were also less likely to be 
prescribed the combination of statins, antihypertensives and antithrombotic medications 
(68.9% vs 82.3%, p<.05). It should be noted, however, that there was significant variation 
between the rural hospitals in terms of prescriptions for antihypertensives. Overall, both 
regions were comparable in terms of dysphagia screening; however, there was significant 
variation between the two urban hospitals on these measures.     
There were no significant regional differences in terms of patients’ discharge 
destinations after adjustment for age, sex, and NIHSS score (OR = 1.24, 95% C.I. 0.81-1.91). 
There were also no significant differences between regions in terms of 30-day mortality, after 
adjustment for age, sex, NIHSS score and Charlson Comorbidity Index score (OR = 0.99, 
95% C.I. 0.46-2.18). The presence of a diagnosis of AF was not independently associated 
with either of the two outcome measures; hence this variable was not included as a covariate 
in either model. 
Discussion 
The primary aim of this study was to describe the regional differences in acute ischaemic 
stroke care within Tasmania. We found that thrombolysis was not administered to any 
patients admitted to the rural hospitals during the study period. Suboptimal access to 
thrombolysis in rural areas has been reported numerous times both within Australia (62, 105) 
and internationally (124, 125), and is acknowledged to be the product of multiple structural 
and patient-related factors (126). Notwithstanding, progress has been made in this area 
elsewhere in Australia (127), primarily through the introduction of ‘telestroke’ services (128). 
The absence of such a facility in Tasmania would appear to be an obvious impediment to 
providing thrombolysis in the state’s rural areas. 
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No patients admitted to the study’s rural hospitals received care in an ASU, as neither 
of the study’s rural hospitals were equipped with these units. This is a concerning finding, as 
unlike the case of thrombolysis, all stroke patients may benefit from admission to an ASU 
(129). Australia’s Stroke Foundation (59) recommends that hospitals receiving over 75 acute 
stroke admissions annually should be equipped with an ASU – a figure which, when 
combined, this study’s nearby rural hospitals would easily surpass (130). The centralisation 
of acute stroke services has been implemented elsewhere with moderate success (131, 132). 
Both the Stroke Foundation (133) and a local clinical advisory group (130) have lobbied 
unsuccessfully to have NW Tasmania’s acute stroke services centralised in an ASU located at 
the NWRH.     
We found that patients admitted to the rural hospitals were less likely to receive 
secondary prevention on discharge; this was particularly the case for patients requiring 
anticoagulants for AF. It is worth noting, however, that the average among urban hospitals 
for this indicator (96.9%) was substantially higher than the national average of 70%. 
Similarly, although the study’s rural hospitals were less likely to provide patients with the 
combination of statins, antihypertensives and antithrombotics on discharge, their performance 
was almost identical to the national average, and considerably higher than the average among 
AuSCR hospitals. These findings likely reflect the combined benefit of ASU care and the 
presence of specialist nursing and neurology staff within the study’s urban hospitals. 
The secondary aim of this study was to describe urban-rural differences in ischaemic 
stroke patient outcomes within Tasmania. Despite differences in access to ASU care and 
thrombolysis, it was pleasing that we did not observe any significant differences between 
urban and rural patients in terms of 30-day mortality or discharge destination. It is possible 
that a longer follow-up period is required to detect any differences in mortality outcome 
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relating to variation in care. For instance, the AuSCR reports risk-adjusted rates of mortality 
at up to 180 days post-stroke (134).  
Our study has several limitations. Firstly, this study was limited to a relatively small 
sample from only four hospitals, all of which are situated in either ‘inner regional’ or ‘outer 
regional’ areas. The absence of data from large metropolitan centres, and equally, from small 
remote hospitals, prevents us from drawing conclusions about how stroke care and outcomes 
differ between these two extremes. Secondly, the study was reliant on the quality of 
documentation within patients’ case notes. Some forms of care (e.g. patient education on risk 
factors) may be informal in nature, and therefore less likely to be documented than more 
systematic processes, such as the prescription of medications. The observed regional 
differences for such indicators may therefore reflect differences in documentation rather than 
underlying care processes.  
Thirdly, when abstracting data on care process measures from patients’ medical 
records, the researchers did not calculate a measure of inter-rater reliability. As an alternative 
means of maintaining inter-rater reliability, the data abstractors consulted the main researcher 
with any ambiguities prior to inputting data into the collection tool. A further limitation 
relates to the absence of a measure of patients’ functioning at the time of discharge. The use 
of a validated measure, such as the mRS, would have provided further information about 
regional differences in patient outcomes, whilst allowing for comparisons with previous 
Australian studies which also used the measure (96). Nonetheless, patients’ discharge 
destination has been found to be highly predictive of mRS scores at three months post-stroke 
(135), and hence may be an appropriate surrogate marker.  
Lastly, because patient deaths were relatively infrequent within the follow-up time 
frame, we were likely underpowered to detect a difference in this outcome measure during 
hospitalisation or at 30-days post-stroke. In spite of these limitations, our study is the first to 
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take an in-depth look at the state of acute stroke care and its associated outcomes within 
Tasmania. These findings will provide a useful baseline to future researchers and 
policymakers who are seeking to improve the delivery of acute stroke care within the state 
(e.g. via the potential expansion of new telehealth initiatives).   
Conclusion 
With the exception of thrombolysis and ASU care, patients treated for stroke in Tasmania’s 
rural hospitals received a standard of care comparable to that of the state’s urban hospitals. 
This is an encouraging finding. Further research is needed, however, to determine which 
factors influence clinicians’ ability to provide acute stroke care in both settings. In addition, 
we did not observe any significant regional differences in terms of patient outcomes. Future 
research in this area should employ larger datasets, which capture a broad sample of large 
metropolitan sites and smaller rural sites.  
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4. CHAPTER FOUR: Health care providers’ perceptions of factors that 
influence the provision of acute stroke care in urban and rural settings: A 
qualitative study 
 
Chapter three sought to describe the regional differences in acute ischaemic stroke care and 
outcomes within the Australian state of Tasmania. The current chapter sought to 
contextualise these quantitative findings by interviewing clinicians from the subject hospitals, 
to determine which factors influenced their ability and willingness to provide guideline-
recommended acute stroke care. 
 
This work was published in SAGE Open Medicine: 
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Introduction
Stroke continues to place a heavy burden on our society. On 
a global scale, stroke accounts for 5.5 million deaths annu-
ally, and personally affects one in four people during their 
lifetime.1 Within Australia, stroke is the third leading cause 
of death,2 costing the Australian economy in the order of 
$5 billion annually.3 Thankfully, the management of acute 
stroke has evolved from an era of therapeutic nihilism4 to 
one in which numerous evidence-based interventions are 
readily available. Indeed, contemporary models of acute 
stroke care typically involve a host of different nursing, med-
ical and allied health professionals, beginning with the deliv-
ery of hyperacute therapies and concluding with the patient’s 
rehabilitation.5,6 In many developed nations, these treatment 
modalities have been collated into sets of guidelines, in an 
effort to bridge the divide between evidence and clinical 
practice.7 A key example of this is the Australian Commission 
on Safety and Quality in Health Care’s Acute Stroke Clinical 
Care Standard, which outlines the care that patients with 
stroke should expect to receive within Australian hospitals.8
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Regrettably, the care processes which comprise the 
Clinical Care Standard are not used ubiquitously, with indi-
viduals in Australia’s rural areas seemingly having inferior 
access to acute stroke care.9,10 In order to begin to address 
this disparity, it is necessary to understand the factors which 
may influence clinicians’ ability to provide care in line with 
what is considered current best practice.11 Moloczij et al.12 
interviewed nursing and medical staff in a regional Victorian 
hospital, finding that the clinicians’ main barrier to using tel-
emedicine consults with metropolitan centres was their scep-
ticism of the use of thrombolysis. This study and several 
others in the area of acute stroke13 have been exclusively 
concerned with the delivery of thrombolysis. Very few stud-
ies have examined the factors influential to acute stroke 
management in its entirety,14 and fewer still have looked at 
how such factors may differ between urban and rural con-
texts. The aim of this study was to interview clinicians 
located in urban and rural settings, to determine which fac-
tors influence their ability and willingness to provide guide-
line-recommended acute stroke care.
Methods
Study design
This qualitative study was undertaken as part of a broader, 
mixed method sequential explanatory study. Semi-structured 
interviews and focus groups were used to explore with clini-
cians the barriers and facilitating factors they experience 
when providing acute stroke care, and whether there are dif-
ferences between urban and rural settings.
Participants and settings
This study took place in the Australian state of Tasmania, 
which has an estimated population of 528,000.15 Tasmania 
has four tertiary level health care centres, the largest of which 
is the Royal Hobart Hospital (RHH), with a maximum capac-
ity of 470 beds.16 The Launceston General Hospital (LGH), 
with 300 beds, serves much of the state’s north and north 
east.17 Both the LGH and RHH have neurology staff on-site. 
The Mersey Community Hospital (MCH) and North West 
Regional Hospital (NWRH) are smaller rural hospitals with 
capacities of 100 and 160 beds, respectively.18 Acute stroke 
cases presenting to the MCH and NWRH are handled by gen-
eral medical physicians. In Australia, regions are classified in 
terms of their remoteness using the Accessibility/Remoteness 
Index for Australia 2011 (ARIA+) system, based on access 
to services.19 According to this system, the MCH and NWRH 
are in ‘outer regional’ areas, while the LGH and RHH are 
situated in ‘inner regional’ areas. For the purpose of this 
study, the MCH and NWRH were regarded as ‘rural’ hospi-
tals, while the RHH is referred to as an ‘urban’ hospital.
Participants were purposefully selected clinical staff from 
the RHH, MCH and NWRH. Clinicians from the LGH were 
not recruited for this study; the researchers were primarily 
concerned with describing the contrast between urban and rural 
settings, as opposed to the experience of acute stroke care 
within all four of Tasmania’s hospitals. In order to be consid-
ered for recruitment, clinicians were required to be involved in 
the delivery of ‘acute stroke care’ as defined by the Australian 
Commission on Safety and Quality in Health Care’s Acute 
Stroke Clinical Care Standard.8 These included clinicians from 
a range of health professions, including general medicine, neu-
rology, nursing, pharmacy and physiotherapy.
Staff specialists at all three hospitals were contacted via 
email and asked for details of a regular meeting in their hos-
pitals which would be an appropriate forum for conducting a 
focus group. Staff specialists were also asked to nominate 
potential participants to be involved in individual interviews. 
Those nominated were contacted and asked to participate in 
interviews, and to nominate any other clinicians with rele-
vant experience in the provision of acute stroke care. 
Participants were given the option of participating in a focus 
group, interview or both. Those who agreed to participate in 
either a focus group or interview provided their written con-
sent after being provided with an information sheet outlining 
the aims of the study. All focus groups and interviews were 
conducted in meeting rooms inside the participants’ place of 
work. No individuals other than the researcher and partici-
pants were present during focus groups and interviews.
Data collection
A semi-structured interview guide was used to elicit discus-
sion in both focus groups and interviews (Supplemental 
Material 1). The interview guide was based on the care pro-
cesses which comprise the abovementioned Clinical Care 
Standard,8 and are detailed in Table 1.20 For each care process, 
the lead researcher (M.D., a male PhD candidate) asked par-
ticipants for an explanation of how the process worked, and a 
description of the factors that helped or hindered this. All 
interviews and focus groups were audio recorded and tran-
scribed verbatim by a third party. The lead researcher used 
field notes and memos written following focus groups and 
interviews to advance and contextualise data analysis. Data 
collection ceased once data saturation was achieved (i.e. when 
the barriers or facilitators that emerged from the data became 
repetitive and there were no more new findings). Reporting of 
the data was guided by the consolidated criteria for reporting 
qualitative research (COREQ) (Supplemental Material 2).
Data analysis
The researchers used an inductive approach to thematic anal-
ysis, in accordance with the six phases described by Braun 
et al.21 This began with the lead researcher reading and re-
reading the transcripts making initial analytical observations 
about the data. Coding was data-driven and the initial coding 
helped to organise the data into meaningful groups. Coding 
was through the software programme NVivo version 12.22 
The codes were then sorted to form themes and subthemes. 
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Themes were reviewed and refined and then named and 
defined. Two other researchers (K.F. and K.M.F.) cross-
checked the outcomes of this process.
Ethical considerations
Ethical approval to conduct this study was obtained from the 
Human Research Ethics Committee of Tasmania (applica-
tion number H0017665).
Results
A total of five individual interviews and two focus groups 
were conducted. The researchers deemed that no further 
focus groups or interviews were required after getting suffi-
cient representation from the various clinical groups (and 
achieving data saturation) in the initial round. Table 2 pro-
vides an overview of the participating clinicians from each 
region. All of the clinicians who were invited to be inter-
viewed agreed to do so. The first focus group was conducted 
at the NWRH as part of this hospital’s weekly general medi-
cal team meeting. Present during this focus group were five 
members of this hospital’s general medical team and one 
physician based at the MCH. The second focus group was 
held at the RHH during the hospital’s neurology depart-
ment’s weekly meeting, and included six members of the 
hospital’s neurology team, along with one resident medical 
officer. Individual interviews were conducted with one phar-
macist each from the NWRH and RHH, and one physiother-
apist each from the NWRH and RHH. In addition, one 
individual interview was conducted with a senior nurse from 
the RHH. All sessions lasted between 30 min and 1 h. There 
were no clinicians who participated in both a focus group 
and an interview.
Themes
The following four overarching themes were identified from 
analysis of the focus groups and interview data: systemic 
issues, clinician factors, additional support and patient-
related factors. Each theme was divided into a series of sub-
themes to provide structure and to demonstrate the hierarchy 
of meaning within the data.
Systemic issues
This theme refers to the way in which the surveyed hospitals 
were configured to deliver stroke care. Three subthemes 
within the theme systemic issues were: protocols, infrastruc-
ture and staffing.
Protocols. Several clinicians mentioned the role that estab-
lished protocols play in their provision of acute stroke care. 
One urban clinician stated that the use of a discharge check-
list covering medications and lifestyle modification advice 
improved their ability to provide patients with these aspects 
of care. In contrast, rural clinicians noted that the absence of 
such a checklist from their hospitals was a barrier to provid-
ing recommended medications and lifestyle modification 
advice. Other clinicians based in the large urban hospital 
referred to several protocols which they believed facilitated 
stroke care. These were the use of blanket physiotherapy 
referrals for stroke, multidisciplinary meetings and the use of 
sequential screening for dysphagia. Finally, a rural-based 
speech pathologist commented that the timely assessment of 
patients for dysphagia was facilitated by a stroke protocol 
which required speech pathologists to service their hospitals’ 
emergency department (ED).
Infrastructure. It was acknowledged that the smaller rural 
hospitals did not have an acute stroke unit (ASU). Urban 
neurologists mentioned that their ability to use computed 
Table 1. Care processes discussed during focus groups and 
interviews.
•  Transport to a hospital able to provide thrombolysis
•  Thrombolysis in ischaemic stroke (with exclusions)
•  Presentation and intravenous thrombolysis within 4.5 h of
symptom onset
•  Thrombolysis within 60 min of hospital arrival
•  Time from onset of symptoms to thrombolysis
•  Admission into a stroke unit
•  90% of acute hospital admission episode time spent on a
stroke unit
•  Assessment for rehabilitation by a physiotherapist within 48 h
of admission
•  Rehabilitation therapy within 48 h of initial assessment
•  Treatment for a rehabilitation goal commencing during an
acute admission
•  Discharge on statin, antihypertensive and antithrombotic
medications
•  Discharge on oral anticoagulants for atrial fibrillation
•  Risk factor modification advice before leaving the hospital
•  Dysphagia screening within 24 h
•  Dysphagia screen passed before first oral intake of fluids,
nutrition or medications
Table 2. Participant characteristics.
Interviews Urban Rural
 Male – 1
 Female 3 1
 Pharmacists 1 1
Senior nurse 1 –
 Physiotherapists 1 1
Focus groups
 Male 4 5
 Female 4 1
General medical physicians 1 6
 Neurologists 7 –
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tomography (CT) perfusion imaging (as opposed to conven-
tional CT imaging) improved their ability to offer thrombol-
ysis. The urban neurologists also mentioned that the capacity 
of the wider hospital impacted their ability to admit stroke 
patients under the hospital’s ASU. The RHH ASU is situated 
inside the hospital’s medical specialties ward and does not 
have any quarantined beds of its own. This, in turn, meant 
that demand for beds from other medical specialties could 
prevent stroke patients from reaching the ASU. Similarly, the 
need for the RHH to clear patients from its ED and intensive 
care unit (ICU) often resulted in patients becoming medical 
outliers (i.e. where patients were admitted to wards other 
than their ‘home’ ward).23 An urban physiotherapist noted 
that such patients may have, in turn, experienced delays to 
their physiotherapy assessments, given that they were not 
‘flagged’ as stroke patients:
If we haven’t got enough beds here to put people in; they outlie 
wherever around the hospital wherever there’s a bed. So, there’s 
not a lot of thought goes into it. And then it’s all driven by ED 
because you might have someone, say, for example, over on a 
ward that’s been there for three days and you really want to get 
them to the Stroke Unit, but if there’s someone in ED, no matter 
if they’re a stroke or something else, they get priority because 
it’s all about ED. (Senior Nurse, RHH)
Staffing. Staffing constraints were identified as a barrier to 
the assessment and treatment of dysphagia in the urban 
hospital. In this hospital, initial assessments for dysphagia 
were generally conducted by ED nursing staff, with subse-
quent treatment handled by speech pathology. A shortage 
of speech pathologists and a lack of ED nursing staff capa-
ble of screening patients for dysphagia were both reported 
by the hospital’s neurologists. The issue of staffing in rela-
tion to workload was also identified. Physiotherapists at 
both urban and rural sites cited their excessive workload as 
being the main reason why they were unable to assess 
patients in a timely manner. Urban physiotherapists 
regarded the use of a weekend physiotherapy service and 
dedicated stroke physiotherapists as being beneficial to 
providing patients with timely assessment and treatment. 
Conversely, in the smaller rural hospitals, staffing physio-
therapy on weekends was seen to be inadequate and of lit-
tle benefit to patients recovering from stroke. This was 
because the rural hospitals’ weekend service was staffed 
with only one physiotherapist, and priority was given to 
orthopaedic patients.
Clinician factors
This theme captures how the attitudes and beliefs of clini-
cians influenced the delivery of acute stroke care. Three sub-
themes were established under the theme of clinician factors; 
these were prescribing styles, clinician preferences and pro-
tocol adherence.
Prescribing styles. There were clear differences between 
regions in terms of how medications were prescribed. 
General medical physicians from the rural hospitals held 
varying perspectives on how aggressively certain risk fac-
tors (e.g. hypertension) should be treated in the wake of 
stroke. This was corroborated by a pharmacist from one of 
the rural hospitals. The same rural pharmacist noted that 
rural doctors may have lacked familiarity with certain 
medicines (e.g. newer generation antithrombotic treat-
ments for atrial fibrillation) causing them to defer the task 
of prescription to outpatient cardiologists or general prac-
titioners (GPs). Neurologists from the RHH attributed 
their relatively higher rates of prescription to a handful of 
reasons. One urban neurologist believed that they were 
‘vigilant’ when it came to prescribing recommended medi-
cations, and hesitant to rely upon other clinicians (e.g. 
GPs) to initiate medications:
I guess maybe we’re cynical and we realise that if we leave 
decisions for other people to make regarding medications that 
they don’t always happen. (RHH Neurologist)
The same clinician pointed out that urban neurologists often 
used magnetic resonance imaging (MRI) scans to determine 
the source of a stroke. This, in turn, made it easier for the neu-
rologists to identify and target specific risk factors. Another 
urban neurologist speculated that the supervision available to 
junior clinicians at the RHH from their superiors might be 
greater than in the rural hospitals, and that this may have facil-
itated the prescription of recommended medications.
Clinician preferences. Clinicians from all three hospitals gen-
erally agreed that some of the care processes featured in the 
Acute Stroke Clinical Care Standard were not appropriate to 
be measured in their hospitals. This was particularly the case 
for the variables relating to the pre-hospital and ED assess-
ment of individuals suspected of having a stroke. ED doctors 
emphasised that the process of assessing stroke patients in an 
ED was not amenable to a ‘tick box’ exercise, such as the 
F.A.S.T. tool,24 as is suggested in the Acute Stroke Clinical 
Care Standard. ED doctors further noted that stroke cases 
present with a variety of symptoms, and the process for 
assessing these patients invariably works through a range of 
differential diagnoses before arriving at a provisional diag-
nosis of stroke. On a related note, urban neurologists men-
tioned that the neurological examinations performed by ED 
doctors were sometimes inadequate to identify all stroke 
presentations, leading to a delay in the stroke protocol being 
activated. One urban nurse also noted that some of the hospi-
tal’s ED doctors were not entirely supportive of using throm-
bolysis for acute ischaemic stroke.
Physiotherapists from both regions and one senior nurse 
from the RHH did not believe it was appropriate to measure 
‘written care plans’ or ‘carer needs assessment/training’ at 
their sites. The clinicians agreed that such processes were 
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more closely aligned with rehabilitation care within the 
Tasmanian system, which was typically provided on a sepa-
rate ward. One rural physiotherapist speculated that these 
indicators were written in the context of larger urban hospi-
tals, which may have less of a demarcation between the acute 
and rehabilitation care provided to stroke patients. Finally, a 
senior nurse from the RHH also noted that clinicians involved 
in hospital bed allocation were at times unaware of the ben-
efits of ASU care over conventional ward care. In her view, 
this increased the likelihood of stroke patients being allo-
cated to outlying wards instead of the hospital’s ASU.
Protocol adherence. Several clinicians mentioned how their 
colleagues’ reluctance to comply with stroke care protocols 
presented a barrier to delivering best practice care. For 
instance, speech pathologists from the rural hospitals noted 
that once patients had been started on the stroke care path-
way, it was common to see ‘nil by mouth’ patients being 
given food and oral medications. The same phenomenon was 
reported by an urban neurologist.
Additional support
This theme covers instances where clinicians acted beyond 
the scope of their usual roles to assist colleagues in providing 
aspects of acute stroke care. This theme contained subthemes 
in relation to the role of each hospital’s pharmacy depart-
ment and the RHH’s expert clinical nurse consultant (CNC).
Pharmacy. An urban pharmacist highlighted that while it was 
the primary responsibility of the neurology department to pre-
scribe secondary prevention medications, pharmacists had a 
facilitating role in this process. By attending ward rounds and 
multidisciplinary meetings, urban pharmacists had the oppor-
tunity to make suggestions about medications which may have 
otherwise been overlooked by medical staff. The same phar-
macist also noted that having the ability to conduct multiple 
medication reconciliations throughout a stroke patient’s admis-
sion increased the likelihood of patients being discharged with 
the necessary and correct medications. A senior physician 
based at one of the rural hospitals noted that the absence of 
pharmacists from their ward rounds was a barrier to prescrib-
ing the necessary medications for patients. One medical regis-
trar from the NWRH also mentioned that pharmacy would 
typically only audit patients’ medication at admission and 
discharge, missing opportunities to identify instances where 
medications had not been charted.
Expert CNC involvement. Clinicians in one of the rural hospi-
tals acknowledged that the absence of an expert CNC and 
ASU at their site was barriers to providing patients with 
advice about reducing their risk of another stroke:
This is why a proper stroke unit or a dedicated unit is really 
important, because everything is geared towards not just the 
rehab or the medicine, but patient information and patient 
education and relatives’ education. (NWRH General Medical 
Physician)
A senior nurse described the facilitating role of the expert 
CNC in a range of different processes which were not their 
primary responsibility. This included assisting with allied 
health referrals, completing dysphagia assessments and ensur-
ing that patients were prescribed all the necessary discharge 
medications. One urban pharmacist also noted that the hospi-
tal’s expert CNC engaged with patients and provided them 
with tailored advice on reducing their risk of secondary stroke.
Patient-related factors
This theme refers to instances where patients’ characteristics 
influenced clinicians’ ability to provide the patient with best 
practice care. Neurologists and a senior nurse from the RHH 
mentioned how patient behaviour was particularly relevant 
to the provision of thrombolysis, which requires patients (or 
their significant others) to identify stroke symptoms and seek 
medical assistance in a timely manner:
. . . it’s the patient factor, so it’s being either witnessed onset or 
being found early. It’s then somebody calling an ambulance you 
know as soon as they’re found. And so, to me that’s public 
education which is hopefully going to improve this year with 
some extra money. (Urban neurologist)
The same group of clinicians noted that patients who pre-
sented with atypical symptoms also presented a challenge to 
the timely delivery of care. This was particularly the case for 
posterior circulation strokes, which were often mistaken for 
more common neurological complaints, and triaged as non-
urgent cases as a result. This initial misdiagnosis was associ-
ated with delays (and subsequent contraindication) to 
thrombolysis and delays to dysphagia screening. Finally, one 
rural clinician reported that providing patients with informa-
tion on modifying their lifestyle to reduce their risk of stroke 
was difficult in patients with poor engagement.
Discussion
This study aimed to identify barriers and facilitators to the 
provision of acute stroke care in urban and rural settings. The 
overall barriers and facilitating factors are discussed in the 
context of existing literature below.
Barriers
Bed shortages in the urban hospital were seen to impact cli-
nicians’ ability to treat their patients within the hospital’s 
ASU. These findings are consistent with an earlier audit 
conducted by Australia’s National Stroke Foundation. The 
Foundation’s 2017 Acute Services Report9 highlighted that 
while 75% of surveyed hospitals had stroke units, only 45% 
of patients spent the majority (i.e. 90% or more) of their 
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hospital admission in ASUs. Staffing and workload con-
straints were viewed by rural clinicians as a barrier to treat-
ing patients in a timely manner. These findings align with 
that of Lindsay et al.,25 who reported that high caseloads and 
staff shortages were among the main workplace stressors 
encountered by a cohort of physiotherapists from regional 
Victoria, Australia. The introduction of a limited weekend 
physiotherapy service in the smaller rural hospitals to 
address this issue was seen to be of little benefit, given the 
emphasis placed on non-stroke patients. This issue of ser-
vice prioritisation (or rationing) was previously identified 
by Adams et al.26 as a major barrier to providing physiother-
apy services within Australia’s rural areas.
The general medical teams of the rural hospitals were 
somewhat less accustomed to treating acute stroke patients 
than their urban counterparts. This is likely due to the special-
ist nature of the urban hospital’s neurology team, and the hos-
pital’s relatively higher patient volumes. The rural hospitals, 
however, are staffed by general medical physicians for whom 
acute stroke cases represent only a small proportion of their 
admissions. Previous studies have reported associations 
between higher stroke patient volumes and improved care27 
and outcomes.28 This could be achieved in Tasmania by hav-
ing acute stroke services for both rural hospitals amalgamated 
into one ASU located in the NWRH,29 as has been suggested 
by local clinicians previously. The absence of a stroke CNC 
within the rural hospitals was viewed as a significant barrier 
to counselling patients about their lifestyle behaviours. This 
finding adds to an existing body of literature documenting the 
beneficial effect of specialist nursing care on the care and out-
comes of individuals who have experienced a stroke.30 It is 
foreseeable that with an increase in patient volumes, smaller 
rural sites such as the NWRH could justify employing a 
stroke CNC. Delays in stroke symptom recognition (e.g. by 
patients or their significant others) were associated with 
delays to thrombolysis. Patient symptom recognition is a 
commonly reported barrier which has been described at 
length by previous authors.31–33 Similarly, clinicians’ recogni-
tion of stroke symptoms was viewed by urban clinicians as 
being a barrier to providing care. This was particularly the 
case for patients with posterior circulation strokes undergoing 
investigation in the hospital’s ED. The issue of misdiagnosis 
in posterior stroke and its impact on patient outcomes have 
been identified by previous authors.34–36 An increased use of 
MRI37,38 and the use of novel stroke screening tools39,40 are 
among the interventions which have been proposed to 
decrease the rate of misdiagnosis.
Facilitating factors
The management of stroke patients within the large urban 
hospital was facilitated by a comprehensive, vigilant and 
team-oriented approach towards patient care. The urban hos-
pital also had a strongly protocol-driven approach towards 
acute stroke care, central to which was the role of the hospi-
tal’s expert CNC. These protocols (e.g. multidisciplinary 
care) are hallmarks of ASU care,41,42 and therefore likely 
reflect the beneficial impact of this hospital’s ASU on stroke 
care. In terms of early rehabilitation, the presence of dedi-
cated stroke physiotherapists and an adequate weekend ser-
vice within the urban hospital facilitated the timely treatment 
of patients. The level of pharmacy involvement in care plan-
ning influenced the extent to which patients received the nec-
essary medications in both regions. This is consistent with the 
findings of a recent systematic review,43 which reported that 
increased pharmacy involvement in stroke care was associ-
ated with an increase in the use of evidence-based therapies, 
medication adherence and risk factor target achievement.
This study contains some limitations which must be 
addressed. Our study was limited to three hospitals, all of 
which are located within one state of Australia. Moreover, 
this study applied definitions of ‘urban’ and ‘rural’ to areas 
of Australia which are technically classified as inner and 
outer regional areas. Both of the above factors mean that our 
findings may not be generalisable to other contexts, particu-
larly those in large metropolitan areas and remote areas. 
Second, although this study sought to involve all clinicians 
involved in the provision of acute stroke care, this was not 
achieved in practice. Within both focus groups, the majority 
of comments were made by senior male clinicians, with 
relatively little input from junior clinicians. This may reflect 
the gender distributions within the clinicians’ professions, 
and also the fact that senior clinicians are typically influen-
tial people who generally determine clinical practice. The 
experiences of junior and senior clinicians are likely to dif-
fer greatly, meaning that our findings may not be generalis-
able to all levels of clinicians. Future researchers in this 
field may consider targeting junior clinicians for individual 
interviews, as opposed to focus groups held in the company 
of their superiors. As a final limitation, it should be acknowl-
edged that the interview guide used in this study had not 
been validated or pilot-tested prior to being used. To the best 
of the authors’ knowledge, this is the first study to interview 
clinicians in urban and rural settings about the barriers and 
facilitators they encounter in providing acute stroke care. 
This information will be useful to policymakers seeking to 
reduce regional disparities in access to acute stroke care. 
This study’s findings may also assist clinicians to adapting 
models of acute stroke care from urban hospitals to rural 
settings.
Conclusion
This study identified barriers and facilitating factors expe-
rienced by clinicians responsible for delivering a range of 
acute stroke care processes in urban and rural settings. Care 
provided in the study’s urban hospital was facilitated by a 
host of policies and procedures, which centred around the 
hospital’s ASU and the role of its expert CNC. Systemic 
issues and the misidentification of stroke symptoms – by 
patients or clinicians – were the primary barriers to patients 
accessing this pathway. The smaller rural hospitals, in 
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contrast, were less comprehensive in their delivery of acute 
stroke care, and would likely benefit increasing patient vol-
umes by merging all acute stroke services into one hospital. 
Future researchers in this area are encouraged to obtain the 
perspectives of both junior and senior clinicians.
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5. CHAPTER FIVE: Regional Differences in the Care and Outcomes of 
Acute Stroke Patients: Evidence from the Australian Stroke Clinical 
Registry (AuSCR) 
 
Recognising the limitations of the manual case note audit conducted as part of chapter three, 
the current chapter aimed to build upon this research by employing a much larger sample of 
data from the Australian Stroke Clinical Registry (AuSCR). 
 
This work was submitted to BMJ Open on 13th May 2020, and is currently under review. 
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Regional Differences in the Care and Outcomes of Acute Stroke Patients: 
Evidence from the Australian Stroke Clinical Registry (AuSCR) 
Internationally, evidence suggests that patients with stroke admitted to hospitals located in 
rural or regional areas have limited access to known evidence-based interventions, such as 
thrombolysis and stroke unit care, relative to those treated in urban hospitals (136). There is a 
paucity of research investigating disparities in other, more elementary processes which define 
contemporary standards of acute stroke care, such as the prescription of secondary prevention 
medications. In addition, if there are differences in stroke care between urban and rural 
regions, determining if there are corresponding differences in patient outcomes warrants 
attention so as to permit future exploration of organisational, process or patient barriers 
preventing evidence-based stroke care being received. Overall, prior research on the rural and 
urban outcomes of care has yielded inconsistent findings (136), and is characterised by 
studies with inadequate risk adjustment (137-139), or an indirect focus on urban-rural 
differences in outcomes (140-142). Previous attempts to explore this issue have also been 
reliant on ‘hard’ outcome measures such as rates of mortality and readmission (143-145); 
whereas regional differences in patients’ quality of life has been rarely investigated (146, 
147). The aim of this study was to compare the processes of care and outcomes for patients 
with stroke treated in urban compared with rural hospitals. 
Methods 
Study design 
We used data from Australian hospitals that participate in the Australian Stroke Clinical 
Registry (AuSCR). The AuSCR registry is used to monitor processes of care provided to, and 
the outcomes of, individuals hospitalised with acute stroke or transient ischaemic attacks 
(TIAs) in Australian hospitals (85). Death information (date and cause) from Australia’s 
National Death Index (NDI) are routinely linked to the AuSCR by the Australian Institute of 
Health and Welfare (AIHW) (134). For this study, we used data from 50 hospitals submitted 
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to the AuSCR from January 2010 to December 2015, and we excluded patients admitted with 
TIAs from this analysis. Selection bias is minimised in the AuSCR by use of an “opt-out” 
approach when recruiting participants, whereby all eligible patients are registered unless they 
or their next of kin nominates to have their data excluded (85); during the study period less 
than 3% of potential participants opted out of the registry. Flow charts detailing the number 
of patients lost to follow-up during each year of the study period are contained in Appendix J. 
Patients who did not opt out of the registry, and who were discharged from hospital following 
their stroke, were followed up by trained research staff between 90 and 180 days following 
their index admission (i.e. the first registered event in AuSCR). This process uses a modified 
Dillman protocol (148), whereby two attempts are made to contact patients by post prior to an 
attempt by telephone (149).        
 Collected processes of care in AuSCR up to 2015 were: admission to a stroke unit, 
thrombolysis (ischaemic stroke only), discharge on anti-hypertensive medication, and the 
provision of a care plan. Indicator data with responses of no, unknown, or missing were 
recoded as negative (proportion of missing data ranged from <1% to 5.05%). Regional 
differences in patient mortality were assessed using intervals of 7, 30, 90 and 180 days. 
Participants’ health-related quality of life (HRQoL) data were collected at 90-180 day follow-
up using the EuroQoL-5 dimension-3 level (EQ-5D-3L) instrument (150). Respondents were 
asked to report their health status in five domains (mobility, self-care, usual activities, pain or 
discomfort, and anxiety or depression) with each domain having three possible responses (no 
problems, some problems, and extreme problems). Respondents use a Visual Analogue Scale 
(VAS) to rate their overall perceived health from 0 to 100, with 0 being the worst imaginable 
health state and 100 the best imaginable health state (150). The VAS was coded as 0 for 
individuals who had died within the follow-up period.  
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Statistical analysis 
Hospitals were divided into categories of ‘urban’ or ‘rural’ based on their classification under 
the Australian Standard Geographical Classification Remoteness Area (ASGC-RA) system 
(29). Hospitals located in ASGC-RA category one (i.e. major cities) were regarded as 
‘urban’, while those in categories two or above were regarded as ‘rural’. The majority of 
hospitals (>95%) that contribute data to AuSCR are funded under the public health care 
scheme. Participants’ baseline characteristics were compared between regions using χ2 tests 
for categorical data, and Wilcoxon Rank Sum tests for continuous variables. Care processes 
were expressed as the proportion of eligible patients who received each form of care and 
were analysed by location (urban or rural) using χ2 tests. Participants’ responses to the EQ-
5D-3L instrument were expressed as the number of individuals who encountered problems 
with each domain, with ‘some problems’ and ‘extreme problems’ being recoded into one 
category. Regional differences within each domain were then analysed using χ2 tests.
 Cox proportional hazards regression analysis was conducted to assess deaths within 7, 
30, 90, and 180 days. Logistic regression was used to assess regional differences in each of 
the EQ-5D-3L domains. Models were adjusted for age, sex, year of admission, state, type of 
stroke, ability to walk on admission (as a validated measure of stroke severity) (151) and 
socioeconomic status (SES) using the index of relative socio-economic advantage and 
disadvantage (IRSAD) (152). Each regression model also accounted for inter-hospital 
transfers, in-hospital stroke, and whether the individual received treatment in a stroke unit. 
Patient clustering was adjusted for directly in each of our models, to account for correlation 
between patients admitted to the same hospital. Data were analysed using Stata/SE 12 (153). 
Ethical approval 
All participating hospitals have provided ethical and governance approvals for AuSCR data 
collection and analysis. Ethical approval was obtained from the AIHW to conduct data 
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linkage to the NDI, and from the Tasmanian Human Research Ethics Committee to conduct 
this data analysis (reference H0017787). 
Results 
Between 2010 and 2015, 28,115 episodes of care from 50 hospitals were registered in the 
AuSCR. Of these episodes, 8,159 (29%) were for individuals admitted to hospitals located 
within rural areas. Compared to those from urban areas, individuals from rural areas were 
more likely to have been born in Australia, have an indigenous background, and be of a lower 
SES (Table 1). Rural patients were also more likely than urban patients to be diagnosed with 
a stroke of ‘undetermined’ subtype (8.1% vs 3.6%). Regional differences in the proportion of 
patients discharged home were not observed, but urban patients were more likely to die in 
hospital in the unadjusted comparisons (Table 1). The median LOS for rural patients was one 
day shorter than that of urban patients, and this remained the case after adjustment for 
potential confounders (coefficient -1, 95% CI -1.97 to -.03).     
 When compared to urban patients, those treated in rural hospitals had poorer access to 
several clinical processes of care (Table 3). Specifically, rural patients were less likely to be 
admitted to a stroke unit (odds ratio [OR] = 0.70, 95% Confidence Interval [CI] 0.66 to 0.74), 
receive intravenous thrombolysis in ischaemic stroke (OR = 0.55, 95% CI 0.50 to 0.62), or be 
provided with a care plan at time of discharge (OR = 0.59, 95% CI 0.54 to 0.64). There were 
no significant differences between regions in prescribing rates of anti-hypertensive 
medications at discharge (OR = 0.97, 95% CI 0.91 to 1.03).  
  
65
Table 1. Patient characteristics by region 
 
Characteristics Urban n (%) Rural n (%) p-value 
No. of sites 25  (50) 25  (50)   
No. of cases 19,956  (71) 8,159  (29)  
Female 9,095  (45.6) 3,770  (46.2) 0.335 
Age (years)    
<65 4,910  (24.6) 2,095  (25.7) 0.030 
65-74 4,468  (22.4) 1,887  (23.1)  
75-84 6,141  (30.8) 2,469  (30.3)   
85+ 4,431  (22.2) 1,707  (20.9)  
Median age in years (Q1, Q3)a  76.1 (65.2, 84.2) 75.4 (64.7, 83.6) 0.003 
State    
New South Wales 3,252  (16.3) 805  (9.9) <0.001 
Queensland 6,675  (33.4) 4,401  (53.9)  
Tasmania - 1,118  (13.7)   
Victoria 9,133  (45.8) 1,835  (22.5)  
Western Australia 896  (4.5) -   
Born in Australia 11,916  (59.7) 6,282  (77) <0.001 
Aboriginal/Torres Strait Islander 174  (0.9) 262  (3.2) <0.001 
Index of Relative Socio-economic Advantage 
and Disadvantage 
   
Quintile 1 (most disadvantaged) 2,367  (12.3) 2,557  (34.4) <0.001 
Quintile 2 2,764  (14.3) 1,932  (26)  
Quintile 3 3,335  (17.3) 1,603  (21.6)   
Quintile 4 4,837  (25.1) 1,092  (14.7)  
Quintile 5 (most advantaged) 5,986  (31) 244  (3.3)   
Able to walk on admission (stroke severity) 6,055  (32.7) 2,439  (34.6) 0.003 
Stroke subtype    
Intracerebral haemorrhagic 3,247  (16.3) 1,177  (14.4) <0.001 
Ischaemic  15,962  (80.1) 6,313  (77.5)  
Undetermined 709  (3.6) 658  (8.1)   
Transfer from other hospitals 2,191  (11.2) 1,739  (21.6) <0.001 
In-hospital stroke 1,156  (5.9) 407  (5.1) 0.008 
Length of stay, median (Q1, Q3)a days 6 (3-10) 5 (2-8) <0.001 
Died in hospitalb 2,216  (11.3) 720  (9.5) <0.001 
Discharge destination     
Home 7,353  (41.4) 2,899  (39) 0.092 
Rehabilitation 6,234  (35.1) 2,137  (28.7) <0.001 
Aged care 1,057  (6) 326  (4.4) <0.001 
        Other 3,096  (17.5) 2,077  (27.9) <0.001 
aQ1: 25th percentile; Q3: 75th percentile 
b<5% missing/not documented data. 







Table 2. Health-related quality of life by region 
 
EQ-5D-dimensions Urban n (%) Rural n (%) p-value 
Mobility    
No problems 4,171  (47.1) 1,791  (48.4)  
Some problems 4,056  (45.8) 1,714  (46.4)  
Extreme problems 631  (7.1) 193  (5.2) <0.001 
Self-care    
No problems 5,784  (65.2) 2,499  (67.4)  
Some problems 2,012  (22.7) 872  (23.5)  
Extreme problems 1,069  (12.1) 339  (9.1) <0.001 
Usual activities    
No problems 3,445  (38.9) 1,448  (39.1)  
Some problems 3,590  (40.6) 1,571  (42.3)  
Extreme problems 1,809  (20.5) 688  (18.6) 0.034 
Pain/discomfort    
No problems 4,401  (50) 1,876  (50.9)  
Some problems 3,955  (44.9) 1,622  (44)  
Extreme problems 446  (5.1) 190  (5.1) 0.621 
Anxiety/depression    
No problems 4,632  (52.8) 1,948  (52.9)  
Some problems 3,630  (41.3) 1,527  (41.5)  
Extreme problems 518  (5.9) 208  (5.6) 0.860 
 
Table 3. Processes of care by region   
    
Evidence-based therapies (all states) Urban n (%) Rural n (%) p-value 
Treated in a stroke unit 16,408  (82.2) 6,241  (76.5) <0.001 
Intravenous thrombolysis for ischaemic stroke 2,007  (12.7) 463  (7.5) <0.001 
Discharged on antihypertensives 12,184  (70.6) 4,895  (69.9) 0.315 
Care plan on discharge to community 4,871  (61.3) 1,441  (44.7) <0.001 
  
There were no significant differences between geographical groups in terms of survival up to 
180 days (Table 4). In relation to HRQoL, urban patients were more likely to report ‘extreme 
problems’ with their mobility, self-care and usual activities (Table 2). After adjusting for 
known covariates, there were no regional differences were observed in four of the EQ-5D 
domains, namely Anxiety/Depression, Mobility, Self-care, and Usual Activities (Table 5). 
Rural patients were, however, significantly less likely to have reported symptoms of pain or 
discomfort during the follow up period (OR = 0.88, 95% CI 0.79 to 0.97, p = 0.015). Rural 
patients also had marginally higher perceived health, as measured by VAS, than their urban 
counterparts (70 vs 68, p<0.001). 
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Table 4. Survival analysis of rural stroke patients as compared to urban stroke patients 
      
  Urban Rural   Model* 
Time to death n (%) n (%) p-value HR 95% CI 
Up to 7 days 1,750  (8.8) 769  (9.4) 0.081 0.98 (0.79-1.21) 
8 to 30 days 1,242  (6.2) 491  (6) 0.608 1.02 (0.87-1.20) 
31 to 90 days 745  (3.7) 265  (3.2) 0.055 0.88 (0.73-1.06) 
91 to 180 days 526  (2.6) 202  (2.5) 0.439 0.88 (0.69-1.11) 
 
*Models were adjusted for age, sex, year of admission, state, type of stroke, ability to walk on admission, socioeconomic status, inter-
hospital transfers, in-hospital stroke, and stroke unit admission 
 
Table 5. Outcomes at 90-180 day follow-up of rural patients as compared to urban patients 
       
    Model 
EQ-5D-dimensions Urban n (%) Rural n (%) p-value OR 95% CI p-value 
Mobility 4,687  (52.9) 1,907  (51.6) 0.169 1.02 (0.92-1.13) 0.717 
Self-care 3,081  (34.8) 1,211  (32.6) 0.023 0.92 (0.80-1.06) 0.235 
Usual activities 5,399  (61) 2,259  (60.9) 0.910 0.95 (0.85-1.06) 0.376 
Pain/discomfort 4,401  (50) 1,812  (49.1) 0.376 0.88 (0.79-0.97) 0.015 
Anxiety/depression 4,148  (47.2) 1,735  (47.1) 0.890 0.98 (0.87-1.10) 0.759 
Median VAS (Q1, Q3) 68 (40, 80) 70 (50, 83) <.001 - - - 
       *Models were adjusted for age, sex, year of admission, state, type of stroke, ability to walk on admission, socioeconomic status, inter-
hospital transfers, in-hospital stroke, and stroke unit admission 
 
Discussion 
The primary aim of this study was to assess whether there are differences in the quality of 
care and outcomes for patients treated in urban and rural locations. We found that patients 
admitted to rural hospitals in Australia were less likely to receive some key care processes 
that are recommended in our national stroke clinical guidelines (64). However, for the most 
part, we did not observe corresponding differences in patient 90-180 day outcomes. 
 Patients admitted to rural hospitals were significantly less likely to receive treatment 
in a stroke unit (76.5% vs 82.2%) despite only one rural hospital not being equipped with a 
stroke unit (n=30 episodes of care). This finding suggests that while nearly all rural sites had 
facilities which met the minimum criteria for stroke units (59), many were unable to utilise 
their stroke unit’s full potential. As observed by Dwyer et al. (154), hospitals without 
‘quarantined’ stroke unit beds may be unable to offer specialist care to stroke patients at 
times when there is demand for beds from other medical specialties. Such hospitals may 
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benefit from using clinical coordinators to facilitate organisational change, as recommended 
by Cadilhac and colleagues (155).        
 It should be noted that during the study period only 45% of patients located in 
Australia’s ‘regional’ areas received treatment in a stroke unit, and only 3.3% of all stroke 
unit beds were located in regional areas (62, 156). Taken together, these statistics indicate 
that access to stroke units within rural hospitals participating in the AuSCR was markedly 
better than the national average. Given that there is a well-established link between stroke 
unit admission and access to key aspects of acute stroke care (60), future efforts should focus 
on increasing the number of stroke units within Australia’s regional areas, and improving 
access to existing stroke units.        
 Consistent with other studies, rural patients remained less likely than urban patients to 
be administered thrombolysis. The provision of thrombolysis is known to be influenced by a 
host of patient, clinician and system-related factors (157). Of these factors, patients’ distance 
to hospitals, accessing brain imaging after-hours, and obtaining specialist input are among the 
most pertinent issues encountered by clinicians providing thrombolysis in rural areas (126, 
158, 159). Rural-based clinicians in the Australian state of Victoria have been able to obtain 
specialist input and improve thrombolysis rates through the use of a telemedicine program 
(160). The use of such technology in all regional areas of the country is urgently needed in 
order to increase rates of thrombolysis administration (161). We did not observe differences 
by location in rates of prescription for antihypertensive medications at hospital discharge. As 
has been noted previously (125), this may reflect the fact that the management of patients’ 
blood pressure for primary or secondary prevention is not necessarily specific to stroke, and 
does not require any additional resources. In any case, the rates of prescription for 
antihypertensive medications at discharge from both regions were comparable to those 
observed in recent studies which also used AuSCR data (162, 163).    
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 Despite marked differences in access to stroke unit care and thrombolysis, we did not 
observe any regional differences in rates of survival at up to 180 days post-stroke. This may 
be because access to acute stroke care, when considered in its entirety, was reasonably 
comparable between the study’s urban and rural hospitals. This notion is supported by the 
fact that the study’s rural hospitals, by virtue of their participation in the registry, are likely to 
be highly motivated to monitor and improve their provision of stroke care, and perhaps are 
better resourced than other rural sites.       
 In relation to HRQoL, we observed that with the exception of the pain/discomfort 
domain, there were no significant regional differences in any of the EQ-5D domains or VAS 
scores. These findings stand in contrast to multiple surveys conducted by the Australian 
government, in which rural residents had an overall lower self-reported health status (164, 
165). The disparity between regions in terms of self-reported pain/discomfort may point 
towards regional differences in attitudes towards pain management. Indeed, literature on 
cancer patients in Australia has highlighted that a culture of stoicism and self-reliance within 
rural areas can make individuals less likely to report symptoms of pain (166) and delay 
seeking medical assistance (167).         
 There are other demographic factors which may partially explain this finding. For 
instance, previous researchers using the AuSCR data have found that patients with stroke 
requiring an interpreter are more likely to report symptoms of pain (168). Given that urban 
patients in this study were far less likely to have been born in Australia (i.e. 59.7% vs 77%), 
the impact of the respondents’ English-speaking ability on our findings cannot be discounted. 
Previous research using the AuSCR data has also highlighted that, other factors remaining 
equal, younger people from a lower SES are more likely to report symptoms of 
anxiety/depression (169). We also found that rural patients had a significantly higher 
perceived health status than urban patients (70 vs 68 via VAS); however, it is unlikely that 
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this difference represents a clinically relevant finding (170).    
 Our study design and data have several limitations. Firstly, the distribution of urban 
and rural patients in this study (71% vs 29%) may not reflect that of the broader Australian 
hospital population, which recently stood at 64% and 36%, respectively (171). We also did 
not use any data in relation to participants’ residential addresses. It is therefore possible that 
some individuals who were admitted to urban hospitals resided in rural areas, and vice versa. 
A further limitation is that our HRQoL data did not factor in patients’ health prior to their 
stroke, meaning it is possible that some individuals’ HRQoL deficits may relate to pre-
existing conditions. Despite these limitations, our study is the first of its kind in Australia to 
comprehensively examine urban-rural differences in access to acute stroke care and the 
associated patient outcomes. To the best of the authors’ knowledge, it is also among the first 
in the world to report on urban-rural differences in patients’ quality of life post-stroke. 
Conclusions 
This is the largest study to date examining geographic disparities in processes of stroke care, 
and providing a benchmark for the development and testing of interventions that may have 
the potential to reduce the differences between rural and urban patients with acute stroke. 
Interestingly, while we identified disparities in processes of care, we did not observe any 
association between geographic region and patient outcomes in terms of mortality or HRQoL. 
There are clear opportunities to better understand why the impact of these process of care 
variables on stroke outcomes are more pronounced in urban areas. Our findings underscore 
the importance of understanding how geographical area influences HRQoL; continued efforts 
to determine the impact of stroke care post-discharge are important. Future work in this field 
should also focus on redressing the resourcing disparities, in particular increasing the number 
of rural hospitals which meet the minimum criteria for stroke unit care.  
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6. CHAPTER SIX: General Discussion 
The purpose of this thesis was to characterise and contrast the care provided to, and outcomes 
of, people with stroke across geographical settings. As a starting point, a systematic review 
was conducted to summarise the existing body of literature and identify potential avenues of 
future research. Based on the gaps identified in the systematic review, a retrospective case 
note audit was conducted using data from hospitals in Tasmania, Australia. A qualitative 
study was then undertaken to contextualise these findings and understand how the 
experiences of clinicians operating in urban and rural settings differed from each other. 
Recognising the limitations of the initial case note audit, a second study of this kind was 
conducted using a much larger, more representative sample from the Australian Stroke 
Clinical Registry (AuSCR). The section is written in the first person as I, the primary 
researcher, provide a summary of the four discrete study outcomes. The findings arising from 
these studies are then discussed drawing on current knowledge. Finally, the contribution that 
these studies make to the literature is established. 
6.1  Summary of Study Findings 
• The systematic review (Chapter Two) highlighted that of the 28 studies reviewed, 
most reported that patients in rural areas had comparatively poorer access to stroke 
care than their urban counterparts. The most commonly cited disparity related to 
thrombolysis, and the greatest similarities between regions were found in the area of 
secondary prevention. Overall, however, the literature was American-centric, which 
limited the generalisability of findings to other settings (e.g. those with universal 
healthcare).   
• The DMR study (Chapter Three) showed that no patients in either of the two rural 
hospitals were administered thrombolysis during the study period. These hospitals 
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also did not have acute stroke units. Patients’ access to the remaining care indicators 
was broadly comparable between regions. After adjusting for confounders and 
acknowledging the relatively small sample, there were no significant differences 
between regions in terms of 30-day mortality (OR = 0.99, 95% C.I. 0.46-2.18) or 
discharge destination (OR = 1.24, 95% C.I. 0.81-1.91). 
• The qualitative study (Chapter Four) highlighted that acute stroke care within the 
study’s urban hospital was structured and comprehensive, aided by the hospital’s 
acute stroke unit and specialist nursing support. This stood in contrast to the 
description of care provided in the study’s rural hospitals, which was somewhat less 
comprehensive, and often constrained by an absence of infrastructure or poor access 
to existing resources.   
• The AuSCR study (Chapter Five) indicated that patients in rural hospitals received 
thrombolysis for ischaemic stroke less often (urban 12.7% vs rural 7.5%, p<0.001). 
Rural patients in this sample were also less likely to receive treatment in stroke units 
(urban 82.2% vs 76.5%, p<0.001) and fewer were discharged with a care plan (urban 
61.3% vs 44.7%, p<0.001). No significant differences were found in terms of 
survival, or in overall self-reported quality of life. 
6.2  Study Findings in Context of the Literature  
6.2.1 Time-critical Therapy 
An urban-rural disparity in access to thrombolysis was a consistent theme in both quantitative 
studies. The two rural hospitals surveyed in the DMR study had never offered thrombolysis 
before, and this is likely to have been the case with several of the rural hospitals in the 
AuSCR study. The barriers to delivering thrombolysis in rural areas are numerous and varied 
(126), and many are discussed in chapter four of this thesis. One factor which has hitherto not 
been discussed, and which may partially explain my findings, relates to patient transfers 
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between facilities. Individuals residing in rural areas may be transported, either privately or 
by ambulance, to urban hospitals in order to receive thrombolysis, as occurred in two studies 
included in the systematic review (125, 172). If this pattern occurred in the AuSCR study, it 
would have inflated the number of patients receiving thrombolysis in urban hospitals. Despite 
evidence of poorer access to thrombolysis in rural areas, it is encouraging to see a growing 
body of evidence supporting the use of TPA at longer intervals after the onset of stroke (173, 
174). This represents a promising opportunity for rural areas, where patients’ eligibility for 
thrombolysis is often hampered by the need to travel long distances to reach a major hospital 
(158). 
6.2.2 Stroke Unit Care 
Similar to the issue of thrombolysis, regional disparities in access to stroke unit care was a 
recurring theme throughout this research. The findings of the qualitative study suggested that 
there were two main reasons why patients may not receive treatment in a stroke unit. Firstly, 
and most obviously, there were hospitals which were simply not equipped with stroke units, 
as was the case for both rural hospitals in the DMR study. Secondly, and as evidenced in both 
quantitative studies, there were cases where hospitals with stroke units were unable to 
provide stroke unit care to eligible patients. Participants in the qualitative study attributed this 
phenomenon to overall bed capacity constraints within their hospital. This finding aligns with 
previous research by Darehed et al. (175), who found that a patient’s likelihood of being 
admitted to a stroke unit from ED decreased by 1.5% with each 1% increase in hospital bed 
occupancy above 85%. This is noteworthy, as participants in the qualitative study reported 
that once stroke patients became medical unit outliers, they were less likely to be transferred 
to the hospital’s stroke unit at any point during their admission. Given the harms associated 
with medical outlier status (176), and the benefits associated with stroke unit care (60), these 
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findings highlight that stroke care must be coordinated (e.g. by a stroke CNC) if hospitals are 
to make the best use of existing resources. 
6.2.3 Secondary Prevention 
The systematic review suggested that of all the domains of acute stroke care, the provision of 
secondary prevention medications was generally the most similar between urban and rural 
areas. This finding was also largely confirmed in both quantitative studies. As noted in the 
systematic review, this may be because such treatments are familiar to clinicians, given that 
they are used in the context of many other conditions. The other main aspect of secondary 
prevention involves providing patients with advice on how to reduce their risk of secondary 
stroke through lifestyle changes. This care process was not measured in the AuSCR study; 
however, the DMR study suggested that rural patients were far less likely to be provided with 
this form of care. Such interventions, unfortunately, have limited efficacy in improving 
patients’ body mass index, blood pressure, lipid profiles and medication adherence (177). 
Nevertheless, the provision of advice and education is associated with increased patient and 
carer knowledge, along with aspects of patient satisfaction (80). Therefore, whilst this form 
of care may not be clearly associated with hard outcomes, it is of importance to patients 
themselves, and for this reason, should be addressed if we are to improve the patient-
centeredness of stroke care.  
6.2.4 Outcomes 
Despite notable differences in access to care, particularly in relation to stroke units and 
thrombolysis, I did not observe any consistent regional differences in patient outcomes. This 
is a seemingly counterintuitive finding in light of several publications which have reported 
excess stroke mortality (i.e. deaths per 1,000 population due to stroke) rates in Australia’s 
rural areas (3, 5). My findings appear to be consistent with the US-based Reasons for 
Geographic and Racial Differences in Stroke (REGARDS) study, which found no evidence 
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of an urban-rural divide in stroke mortality following hospitalisation (178, 179). The authors 
of that study and others (180) have attributed rural areas’ excess stroke mortality rates to the 
fact that these regions have higher stroke incidence rates. Put simply, individuals in rural 
areas have higher per capita rates of stroke mortality because they are more likely to have 
strokes in the first place. There is reason to believe that this is also the case in Australia, 
where stroke incidence and hospitalisation rates are both significantly higher in rural as 
compared to urban areas (3, 181). Alas, addressing urban-rural disparities in stroke incidence 
rates is an entirely separate issue with its own potential solutions, and as such, it is beyond 
the scope of this body of work, which is focused on care and outcomes after a stroke event.   
An alternative explanation for these findings is that there was a tenuous association 
between patient outcomes and the care processes which were maldistributed between regions 
(i.e. thrombolysis, stroke unit care). This was almost certainly the case for thrombolysis in the 
context of the DMR study. Given that this drug has a number-needed-to-treat of 14 (182), and 
only 16 subjects received the drug, any protective effect of thrombolysis on 30-day mortality 
rates in this study is likely to have been negligible. It is typically expected that the benefit of 
thrombolysis would manifest as patients’ improved functioning in the medium to longer term, 
as opposed to mortality in the short term (72). It should also be noted that the DMR study 
was not powered in order to detect regional differences in rates of 30-day mortality, as this 
would likely have been impractical using a manual case note audit. Indeed, given the small 
difference between regions on this variable (i.e. 11% vs 10.3%), a sample in excess of 60,000 
cases would have been required for the difference to be considered statistically significant 
(183). Future research in this area should only be conducted using a sufficiently large sample 
with a follow-up period of at least 180 days.   
Where stroke unit care is concerned, it is possible that rural hospitals, seeking to make 
the most of limited resources, had utilised their hospitals’ Intensive Care Units (ICUs) or 
High Dependency Units (HDUs) as substitutes for stroke units. This practice appears to be 
commonplace in the state of New South Wales, where successive audits of acute stroke care 
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have pooled ICU and HDU care together with stroke unit care (184, 185). Whilst this 
approach is unlikely to be as effective as stroke unit care, it would represent a more 
specialised form of care than that of a general medical ward, and hence may have had a 
protective effect on the outcomes of rural patients. 
6.3 Strengths and Limitations 
This body of work is the first of its kind to describe differences in acute stroke care and 
outcomes between Australia’s urban and rural areas using a large sample. This is an 
important contribution to the literature base, as much of the pre-existing literature was written 
from an American-centric perspective. My findings are also strengthened by the use of robust 
statistical modelling with risk adjustment for patients’ stroke severity, the strongest known 
predictor of stroke patient outcomes in the short term (186, 187). The addition of stroke 
severity measures to regression models in both quantitative studies not only adds validity to 
my findings, but also addresses a key limitation of previous studies in the field. The use of a 
sequential-explanatory mixed methods design allowed the qualitative results to assist in 
validating and explaining the trends identified in the DMR study. Lastly, this project has also 
benefited from access to national data and collaboration with subject matter experts from 
Monash University.  
This study also contains methodological limitations which must be addressed. My 
research used the location of the treating hospital as a proxy measure of rurality when 
defining ‘urban’ and ‘rural’ areas, without considering the patient’s residential address. 
Whilst this approach was underpinned by recognised classification systems (e.g. ASGC-RA, 
MMM), there is a risk of misclassification bias resulting from patients receiving treatment 
outside of their native region. This most notably occurs when patients from rural areas travel 
to urban hospitals to receive thrombolysis, as discussed above. Future researchers are 
encouraged to incorporate patients’ residential addresses and the location of the treating 
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hospital when conducting studies of this kind. On a related note, by dichotomising urban and 
rural areas, I was unable to account for the heterogeneity of Australia’s rural areas, which 
vary greatly in their sociodemographic and health indicators (188). This could be overcome 
by grouping areas along a continuum of rurality using bands designated by one of the 
abovementioned classification systems. 
The use of hospital administrative data in the DMR also carries some limitations. 
Firstly, the time-consuming nature of medical record abstraction (189) made it impractical to 
use a large sample. In using a relatively small sample, my study may have been 
underpowered to detect regional differences in outcomes stemming from disparate access to 
thrombolysis. The need to adopt a smaller sample also meant that I could ill-afford to include 
cases of conditions mimicking stroke, which in turn required us to thoroughly screen cases 
before including them in the study. The time spent acquiring, screening and analysing DMR 
data also meant that there was a significant gap between the age of my DMR data, and when 
the qualitative focus groups and interviews took place. This has implications for the 
sequential-explanatory nature of qualitative study, in that the barriers and facilitators 
mentioned by clinicians may have been more relevant to their current context than the period 
when the DMR data occurred.  
There are also limitations associated with my use of data from the AuSCR which must 
be acknowledged. Firstly, the number of care processes collected by the AuSCR (in most 
hospitals only 4) is limited, and hence does not provide a comprehensive account of acute 
stroke care in participating hospitals. Secondly, and as touched on in Chapter Five, the rural 
hospitals participating in AuSCR are unlikely to be representative of all rural hospitals in 
Australia. All but one of these hospitals was equipped with a stroke unit, and anecdotally, 
many of these units would have been staffed by neurologists, making them characteristically 
similar to large urban hospitals. These similarities, coupled with the overall small magnitude 
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of differences in stroke unit care and thrombolysis, may have further contributed to the 
absence of an overall urban-rural divide in patient outcomes. 
Lastly, there are limitations associated with the representativeness of my findings. 
Both the DMR and qualitative studies relate specifically to the Australian state of Tasmania. 
Given that Tasmania’s demographics and risk factor profile is markedly different to the rest 
of Australia (38), my findings may have limited generalisability to other Australian states and 
indeed, other countries. This body of work also did not seek the input of any stroke patients, 
which, as discussed in greater detail below, limited my ability to make inferences about care 
quality from the patient’s perspective.  
6.4 Future Research 
6.4.1 Novel Determinants of Stroke Care and Outcomes 
This thesis took a conventional approach towards characterising acute stroke, focussing on 
the concrete aspects of care and patient outcomes. There is an emerging body of research 
detailing the role of other, more nebulous factors which were previously unmeasured. For 
instance, Andrew et al. (190) used a validated survey to describe the effect of certain 
qualitative factors (e.g. a hospital’s culture and social capital), finding that both were linked 
with an increased use of stroke unit care. Similarly, Bray et al. (191) reported an association 
between a composite measure of staffing (numbers, type, and training level), facilities (e.g. 
continuous physiological monitoring) and service level (e.g. 24/7 availability of emergency 
imaging and thrombolysis) and access to evidence-based care. Additional research is needed 
in this area, as it may further knowledge of what defines urban and rural stroke care. With a 
more holistic understanding of what separates both regions, researchers would be better 
positioned to address disparities in care. 
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6.4.2 Incorporation of Patient-reported Outcome Measures into Clinical Practice 
At a basic level, patient-reported outcome measures (PROMs) are a measure of a patient’s 
health which comes directly from the patient themselves, without interpretation by a third 
party (192). PROMs typically address the patient’s functional status, symptom burden, well-
being and health-related quality of life (193). PROMs are increasingly being used as a 
measure of healthcare quality (194), and therefore hold potential to shed light on differences 
in care quality between regions. Despite the availability of several validated tools which have 
been endorsed for use with stroke patients (194), we are yet to see PROMs incorporated into 
routine clinical practice. If we are to increase the patient-centeredness of the care we provide 
to acute stroke patients, it will be essential to seek the patient’s perspective. The need to 
incorporate PROMs into clinical practice is strengthened by the fact that, as mentioned 
above, some care processes are not associated with the hard outcomes that are traditionally 
collected, and hence there is a need for alternative measures of quality. 
6.5 Recommendations 
6.5.1 An Increased Use of Telestroke  
Stroke telemedicine or ‘telestroke’ refers to the use of audio-visual communication 
technology to facilitate the remote clinical and radiological evaluation of stroke patients 
(195). By assessing patients remotely at their presenting hospital, specialists can provide 
prompt advice around the use of time-critical treatments (e.g. thrombolysis) (196). For this 
reason, telestroke is often used in so-called ‘hub-and-spoke’ networks, where larger, 
predominantly urban hospitals with specialist staff (hubs) provide decision support for 
smaller rural sites (spokes) (197). Having access to specialist input is a great benefit to 
clinicians operating in smaller rural hospitals, who may have otherwise been unwilling to 
administer thrombolysis (161). Telestroke has been successfully trialled in a number of 
countries, and is acknowledged to be a safe, and cost-effective means of improving access to 
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thrombolysis (160, 195, 198). Perhaps the most prominent example of telestroke in Australia 
is the VST, whose implementation has resulted in an increase in the number of patients 
receiving thrombolysis within 60 minutes of arrival to hospital, whilst also decreasing the 
number of thrombolysis-related adverse events (160).   
The use of telestroke in combination with Mobile Stroke Units (MSUs) may also offer 
a solution to narrowing urban-rural disparities in access to thrombolysis. In plain terms, 
MSUs are ambulances equipped with a CT scanner and specialist staff, which would typically 
include paramedics, a radiographer and neurologist or stroke fellow (199, 200). A MSU was 
recently implemented in Melbourne, Australia, serving a 20km radius of the city with an 
estimated catchment of 1.7 million people (199). Whilst there are no data to support their use 
in rural Australian settings, MSUs have been trialled in rural Alberta, Canada. Shuaib et al. 
(200) describe a model where rural-based ambulances collect patients and meet MSUs at a 
predesignated site, where the patients are given a CT scan. The images from the scan are then 
forwarded to a specialist located in a tertiary care centre for review. The specialist may then 
choose to administer thrombolysis and transport the patient to a tertiary care centre (i.e. ‘drip 
and ship’) or transport the patient to the tertiary care centre for other acute treatment (e.g. 
endovascular clot retrieval) (200). Patients may also be directed back to their local hospital 
where deemed necessary (e.g. in the case of stroke mimics), thus reducing the number of 
costly and unnecessary transfers to tertiary care centres (200, 201). 
6.5.2 Increased Access to Stroke Unit Care 
As noted above, suboptimal access to stroke unit care can be divided into cases where a given 
hospital does not have a stroke unit, and cases where the hospital has a stroke unit, but is 
unable to utilise its full potential. In the latter case, it has been suggested that access can be 
improved by increasing staff members’ recognition of stroke units as significant specialist 
units (e.g. as being equivalent to a coronary care unit for myocardial infarction) (202). The 
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use of clinical facilitators in concert with clinical pathways has also been associated with 
increased access to stroke unit care (203, 204). Taking a broader perspective, the use of 
clinical networks with ambulance transfer agreements between sites and hospital pre-
notification may also improve access to stroke units (205). Models of acute stroke care such 
as these have been implemented elsewhere in Australia, and in Denmark and the United 
Kingdom, leading to significant increases in the number of patients receiving stroke unit care 
(131, 132) and thrombolysis (206, 207). Where there are no pre-existing stroke units, and 
patient transfers are infeasible, it has been suggested that consultation via telestroke systems, 
such as those outlined above, may represent the closest alternative to stroke unit care (132, 
208, 209).  
6.5.3 Expanded Data Collection Infrastructure 
There is currently a scarcity of representative data to describe the state of stroke care and 
patient outcomes in Australia. This was exemplified in the DMR study, where the best 
available method of data collection was a labour-intensive process of manual case note 
abstraction, which would be wholly unsustainable as an ongoing means of monitoring stroke 
care. Whilst the burden of data collection and analysis has undoubtedly been reduced with the 
advent of the AuSCR (62), the significant financial costs incurred by hospitals participating 
in the registry could hinder the recruitment of further sites. It is also possible that with the 
current fiscal outlook (i.e. post-COVID-19), some sites will find it difficult to maintain their 
subscription to the registry. As an alternative to commercial clinical registries, some 
government health organisations have developed systems for monitoring stroke care and 
outcomes (185, 210). In other fields, namely cardiac rehabilitation, registries have been 
incorporated into administrative data collection, allowing fields to be prepopulated and thus 
reducing the time needed to enter cases (211). Further development of such state-funded data 
collection programs may represent a more viable alternative than the AuSCR.   
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The use of a state-funded, not-for-profit clinical registry with mandatory participation 
for designated hospitals may also improve the generalisability of data collected. Firstly, by 
having a large pool of uniform data, it would be possible to apply the same risk adjustment 
methodology across all cases, thus increasing the ability to monitor and compare patient 
outcomes. Secondly, by mandating registry participation, there would be opportunities for 
less-motivated and lower-performing sites to learn from, and benchmark against, the high-
performing sites which currently predominate the AuSCR. Providing researchers with access 
to free or concessionally-priced data from a not-for-profit registry would also remove one of 
the barriers to conducting research in this field, which may encourage further research. 
Whilst it is acknowledged that the presence of clinical registry data alone does not ensure 
quality improvement (212), having a sufficient amount of high-quality data available to 
clinicians and policymakers would be invaluable. Indeed, as Westert et al. note, public 
reporting is the first step towards addressing unwarranted variation in medical practice (213). 
6.5.4 A Revision of Stroke Data Variables 
It is apparent that the set of variables currently collected in Australia through various 
initiatives (e.g. via the AuSCR, Stroke Foundation Audits etc.) do not cover acute stroke care 
in its entirety. Of particular note are those relating to dysphagia screening and assessment for 
stroke in the pre-hospital environment. Dysphagia is common in stroke, affecting 27% to 
64% of all patients (214), and patients with dysphagia are significantly more likely to 
experience pneumonia (207), which is itself associated with an increased risk of mortality in 
the short term (215, 216). Despite this, and despite featuring in the Clinical Guidelines (64) 
as a consensus-based recommendation, there are no indicators related to dysphagia 
management in the Clinical Care Standard (114). This represents a missed opportunity to 
utilise the data collection infrastructure of the Stroke Foundation for quality improvement 
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purposes. This could be addressed by creating a robust operational definition for dysphagia 
management, and incorporating it into existing stroke data collection initiatives.  
With regard to stroke screening, some clinicians interviewed as part of the qualitative 
study believed that one stroke screening tool recommended by the ACSQHC (i.e. F.A.S.T.) 
was unfit for purpose, and better suited towards non-clinicians in the community. As a result, 
F.A.S.T. was seldom, if ever, used by these clinicians. Similar reservations were expressed by 
clinicians who were consulted about the ACSQHC’s Acute Stroke Clinical Care Standard 
prior to its release (202). A similar situation was found in the pre-hospital environment, 
where, despite Tasmanian guidelines mandating the screening of suspected stroke patients 
using a validated tool (i.e. the Melbourne Ambulance Stroke Screen) (217), this was not 
widely adhered to. Despite this, there were clear instances in the DMR study where patients 
may have been candidates for thrombolysis, had their stroke symptoms been identified 
earlier. This suggests a need to implement a more clinically-focussed screening tool, such as 
the Recognition of Stroke in the Emergency Room (ROSIER) Scale (218). This particular 
tool was recommended by clinicians in the abovementioned consultation paper (202) and 
therefore may be better received by other clinicians, leading to fewer missed opportunities to 
administer thrombolysis. 
6.5.5 Stroke Follow-up Clinics 
Participants in the qualitative study mentioned a host of barriers to providing patients with 
tailored advice about their lifestyle behaviours while patients are admitted. One solution to 
this may be an increased use of follow-up services for stroke patients, such as the Stroke 
Foundation’s Stroke Outreach Program (StOP) (219). Under this initiative, consenting stroke 
survivors are contacted within 21 days of discharge by a multidisciplinary team from the 
Stroke Foundation to discuss secondary prevention measures. Following the consult, a letter 
about what was discussed is then generated by the Stroke Foundation’s team and sent to the 
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liaising GP and stroke survivor (219). The use of such follow-up clinics has been associated 
with a significant reduction in the odds of readmission at 30 days post-discharge (220) and 
improvements in medication adherence at 12 months (221). Follow-up clinics of this sort 
would also provide an opportunity to address other unmet needs encountered by patients 
post-discharge, as suggested by Kjork et al. (222). It is also foreseeable that in the post-
COVID-19 world, healthcare providers will implement telehealth initiatives in greater 
numbers, which may facilitate this kind of follow-up clinic for stroke.   
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6.6 Recent Developments in Acute Stroke Care in Tasmania 
Both the DMR and qualitative studies relate specifically to the provision of stroke care within 
the Australian state of Tasmania. As of November 2019, there had been several changes 
made to the delivery of acute stroke care since these studies took place:  
6.6.1 Centralisation of Acute Stroke Care 
• The MCH was actively reducing the number of acute stroke cases it was handling, 
instead placing emphasis on becoming a dedicated rehabilitation facility. 
• A general medical physician with an interest in stroke who had been working at the 
MCH during the study period had since transferred to the LGH. 
• Unfortunately, however, there were still no protocols in place for ambulances with 
suspect stroke cases to bypass the MCH and travel directly to the NWRH.  
6.6.2 Telestroke 
• The NWRH had recently appointed a Stroke CNC, whose first objective was to link 
the NWRH with the Victorian Stroke Telemedicine (VST) network. As of March 
2020, both the LGH and NWRH had joined the VST network. 
• It is proposed that the Stroke CNC will eventually spearhead the implementation of a 
new ASU at the NWRH.  
6.6.3 Secondary Prevention 
• The RHH had recently obtained funding to modify existing patient management 
software to include more features tailored towards stroke patients. The project, which 
has been dubbed ‘My Going Home Plan’, is a checklist containing elements of the 
Clinical Care Standard (e.g. secondary prevention medications) which aims to reduce 
the number of patients leaving hospital before receiving adequate care.  
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6.7 Conclusion 
This thesis sought to characterise and contrast the care provided to, and outcomes of, people 
with stroke across geographical settings. Rural hospitals typically offer a comparatively basic 
form of acute stroke care, with less access to stroke units and thrombolysis. Central to 
addressing this disparity will be a reconfiguration of existing resources with an increased use 
of telestroke services. I did not observe any regional differences in patient outcomes, a 
finding which, whilst being consistent with previous studies, may have been influenced by a 
combination of methodological limitations, particularly in relation to sample sizes. 
Policymakers should note that the apparent similarities in patient outcomes between regions 
should not be taken as evidence that both groups received a commensurate level of care. 
Rather, these outcomes belie systemic differences in the way care is provided, which should 
not be ignored. We must work towards reducing this disparity now, while urban-rural 
differences in acute stroke care are primarily an issue of thrombolysis and stroke unit care. As 
Leira et al. (2017) note, this gap will only widen with the increased uptake of more complex 
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Appendix A. PubMed search strategy (Chapter Two) 
1. rural[title] 
2. region*[title]  















18. “Rural Health”[MeSH] 
19. “Socioeconomic Factors”[MeSH] 
20. “Rural Population”[MeSH] 
21. “Urban Health”[MeSH] 
22. “Urban Population”[MeSH] 
23. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or 




27. “Stroke/diagnostic imaging”[MeSH] 
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33. “Stroke/organization and administration”[MeSH] 
34. “Stroke/prevention and control”[MeSH] 
35. “Stroke/statistics and numerical data”[MeSH] 
36. “Stroke/therapy”[MeSH] 




41. “cerebral vascular”[Title] 
42. “cardio vascular”[Title] 
43. CVA[Title] 
44. “subarachnoid haemorrhage”[Title] 
45. “subarachnoid hemorrhage”[Title] 
46. “intracerebral hemorrhage”[Title] 
47. “intracerebral haemorrhage”[Title] 
48. “cerebral infarct”[Title] 
49. “cerebral infarction”[Title] 
50. “brain attack”[Title] 
51. #38 or #39 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50  
52. “Hospitals*”[MeSH] 
53. “Health Services Needs and Demand*”[MeSH] 
54. “Health Services Research”[MeSH] 
55. “National Health Programs”[MeSH] 
56. “Emergency Medical Services/standards”[MeSH] 
57. “Emergency Medical Services/statistics and numerical data”[MeSH] 
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58. “Emergency Medical Services/supply and distribution”[MeSH] 
59. “Hospitalisation”[MeSH] 
60. “Hospitalisation*/trends”[MeSH] 
61. “Patient Care”[MeSH] 
62. “Secondary Prevention*”[MeSH] 
63. “Delivery of Health Care”[MeSH] 
64. “Delivery of Health Care/economics”[MeSH] 
65. “Delivery of Health Care/methods”[MeSH] 
66. “Delivery of Health Care/standards”[MeSH] 
67. “Inpatients”[MeSH] 
68. “Reperfusion”[MeSH] 
69. “Hospital Mortality*”[MeSH] 
70. “Quality Indicators, Health Care/economics”[MeSH] 
71. “Quality Indicators, Health Care/statistics and numerical data”[MeSH] 
72. “Quality Assurance, Health Care”[MeSH] 
73. “Outcome and Process Assessment Health Care”[MeSH] 
74. #52 or #53 or #54 or #55 or #56 or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 
or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73  












Urban Rural   Averages   
 RHH (n=100) LGH (n=100)  MCH (n=95) NWRH (n=100)  Urban Rural P value Nationala AuSCRb 
Transport to a hospital able to provide thrombolysis (with exclusions)† 33/38 (86.8%) 22/28 (78.6%)  0% 0%  83.3% 0% - 71% 76% 
Transport to a hospital able to provide thrombolysis (without exclusions) 33/100 (33%) 22/100 (22%)  0% 0%  27.5% 0%    
Thrombolysis in ischaemic stroke (with exclusions)† 7/12 (58.3%) 9/14 (64.3%)  0% 0%  61.5% 0% - - - 
Thrombolysis in ischaemic stroke (without exclusions) 7/100 (7%) 9/100 (9%)  0% 0%  8% 0% - 13% 14% 
Presentation and intravenous thrombolysis within 4.5 hours of symptom onset 6/12 (50%) 9/14 (64.3%)  0% 0%  57.7% 0% - 38% 31% 
Thrombolysis within 60 minutes of hospital arrival 1/7 (14.3%) 2/9 (22.2%)  0% 0%  18.8% 0% - 30% 39% 
Time from onset of symptoms to thrombolysis (h:mm) (median) 2:30 2:40  - -  2:35 - - 2:36 2:36 
Admission into a stroke unit 80/100 (80%) 73/100 (73%)  0% 0%  76.5% 0% - 69% 73% 
90% of acute hospital admission episode time spent on a stroke unit 61/100 (61%) 43/100 (43%)  0% 0%  52.0% 0% - 45% - 
Assessment for rehabilitation by a physiotherapist within 48 hours of admission 74/95 (77.9%) 66/94 (70.2%)  71/94 (75.5%) 74/99 (74.7%)  74.1% 75.1% .82 67% - 
Rehabilitation therapy within 48 hours of initial assessment 52/65 (80%) 52/67 (77.6%)  51/64 (79.7%) 48/65 (73.8%)  78.8% 76.7% .77 86% - 
Treatment for a rehabilitation goal commencing during an acute admission 61/64 (95.3%) 67/67 (100%)  60/65 (92.3%) 60/65 (92.3%)  97.7% 92.3% .05 90% - 
Discharge on statin, antihypertensive and antithrombotic medications 59/67 (88.1%) 43/57 (75.4%)  50/80 (62.5%) 63/84 (75%)  82.3% 68.9% .01 69% 49% 
Statins 79/82 (96.3%) 72/76 (94.7%)  79/83 (95.2%) 75/86 (87.2%)  95.6% 91.1% .13 - 77% 
Antihypertensives 66/71 (93%) 56/70 (80%)  55/83 (66.3%) 76/86 (88.4%)  86.5% 77.5% .006 - 70% 
Antithrombotics 86/87 (98.9%) 86/86 (100%)  76/83 (91.6%) 84/86 (97.7%)  99.4% 94.7% <.001 - 88% 
Discharge on oral anticoagulants for atrial fibrillation 20/20 (100%) 11/12 (91.7%)  22/29 (75.9%) 10/20 (50%)  96.9% 65.3% <.001 70% - 
Risk factor modification advice before leaving the hospital 32/45 (71.1%) 27/39 (69.2%)  23/42 (54.8%) 16/44 (36.4%)  70.2% 45.3% .001 70% - 
Dysphagia screening within 24 hours 75/86 (87.2%) 57/91 (62.6%)  81/93 (87.1%) 68/96 (70.8%)  74.6% 78.8% .39 49% 80% 
Dysphagia screen passed before first oral intake of fluids, nutrition, or medications 64/85 (75.3%) 31/91 (34.1%)  55/92 (59.8%) 51/94 (54.3%)  54% 57% .14 63% 51% 
 
†Exclusions include presentation >4.5 hours after symptom onset, presence of intracranial haemorrhage, among others (114) 
a Figures obtained from the Stroke Foundation’s 2017 National Stroke Audit Acute Services Report (62) 
b Figures obtained from the 2017 AuSCR Annual Report (86) 












































































Appendix D. Email Script (Chapter Four) 
Hi there, 
Please find attached an information sheet from Mitchell Dwyer, a PhD student with the 
University of Tasmania. Under the guidance of his supervision team (Prof Leigh Kinsman, Prof 
Greg Peterson, Dr Karen Ford and Dr Seana Gall), he is conducting research for a thesis to be 
titled ‘Urban-rural differences in acute stroke care and patient outcomes’.  
He is seeking clinicians who are willing to participate in research relating to the care of acute 
stroke patients within Tasmanian hospitals. Your knowledge and firsthand experiences will 
provide valuable insights which may assist with improving acute stroke care within Tasmania’s 
hospitals.  
If you are willing to participate, could you please email the student directly: 
mitchell.dwyer@utas.edu.au.  
Kind regards, 
[Insert Clinician’s Name] 
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Appendix E. Consent Form (Chapter Four) 
CONSENT FORM 
Health care providers’ perceptions of factors influential to the provision of acute stroke care in urban 
and rural settings: a qualitative study 
1. I acknowledge that the nature, purpose and contemplated effects of the project so far as it affects 
me, have been fully explained to my satisfaction by the research worker and my consent is given
voluntarily.
2. The details of the project have also been explained to me, including the anticipated length of time 
it will take.  I understand that my involvement means participation in a focus group (and
potentially an interview) to discuss the provision of acute stroke care within either the Royal
Hobart Hospital, Mersey Community Hospital, or North West Regional Hospital. Focus groups and 
interviews will each take approximately 1 hour, and will take place at a venue and time
convenient to the participants.
3. I understand that here are no associated risks with participation in this project. There will be a
minor inconvenience due to the amount of time taken to participate in the focus group/interview
process. I am able to withdraw from the interview and the project at any stage without any effect 
on my relationship with my employer.
4. Although I understand that the purpose of this research project is to identify factors which health
service providers deem to be influential to the provision of the acute stroke care processes in
urban and rural areas of Tasmania, it has also been explained that my involvement may not be of
any benefit to me.
5. I understand that no information revealing my identity will be published.
6. I understand that my involvement in the project (or my withdrawal from it) will not affect my
relationship with my employer.
7. I understand that I will be given a signed copy of this consent form and a participant information
sheet.  I am not giving up my legal rights by signing this consent form.
8. I understand that the research will be conducted in accordance with the latest versions of the
National Statement on Ethical Conduct in Human Research and applicable privacy laws.
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Name of participant 
Signature of participant   Date 
I have explained this project and the implications of participation in it to this volunteer and I 
believe that the consent is informed and that he/she understands the implications of 
participation. 
Name of investigator   
Signature of investigator      Date 
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Appendix F. Participant Information Sheet (Chapter Four) 
Health care providers’ perceptions of factors influential to the provision of 
acute stroke care in urban and rural settings: a qualitative study 
PARTICIPANT INFORMATION SHEET 
Invitation 
You are invited to participate in a research study to explore the perceptions of clinicians 
providing acute stroke care in Tasmania’s tertiary care hospitals. 
The study is being conducted by: 
• Mitchell Dwyer, PhD Candidate, School of Health Sciences, University of Tasmania
• Professor Gregory Peterson, School of Medicine, University of Tasmania
• Professor Karen Francis, Head – Nursing Discipline, University of Tasmania.
• Dr Seana Gall, Senior Research Fellow, Menzies Institute for Medical Research,
University of Tasmania.
• Dr Karen Ford, ADON Research & Practice Development, Tasmanian Health Service
Before you decide whether or not you wish to participate in this study, it is important for 
you to understand why the research is being done and what it will involve. Please take the 
time to read the following information carefully and discuss it with others if you wish. 
1. ‘What is the purpose of this study?’
The purpose of this study is to identify factors which health service providers deem to be 
influential to the provision of the acute stroke care processes in urban and rural areas of 
Tasmania. 
2. ‘Why have I been invited to participate in this study?’
You have been invited to participate in this study, as your professional group is involved in 
the provision of acute stroke care to patients admitted to Tasmania’s tertiary hospitals.   
3. ‘What if I don’t want to take part in this study, or if I want to withdraw later?’
Participation in this study is voluntary. It is completely up to you whether or not you 
participate. If you decide not to participate, or to withdraw from the study, it will not affect 
your relationship with your employer.  If you choose to withdraw from the study during the 
focus group or interview, please inform the researcher. Please note it may not be possible 
to withdraw your data from the study results.   
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4. ‘What does this study involve?’
If you agree to participate in this study, you may be involved in one of two ways:
Participation in a focus group
• You may volunteer to participate in focus groups with other health care
professionals from your workplace who are involved in the provision of acute stroke
care.
• The purpose of the focus groups is to identify factors which health service providers
deem to be influential to the provision of the acute stroke care processes in urban
and rural areas of Tasmania. For the purpose of this study, the Royal Hobart Hospital
will be considered an ‘urban’ area, while the Mersey Community Hospital and North
West Regional Hospital will be considered to be ‘rural’.
• Each focus group will take 45-60 minutes
• Focus group meetings will be audio recorded to help ensure accurate reporting of
the findings.
Participation in an interview 
• You may volunteer to participate in a one-to-one interview with one of the
researchers, as an alternative to attending a focus group.
• The purpose of these interviews is identical to that of the focus groups.
• Interviews will take 45-60 minutes, and will be audio recorded to help ensure
accurate reporting of the findings.
5. ‘How is this study being paid for?’
There is no dedicated funding for this research. The PhD candidate, Mitchell Dwyer, is in 
receipt of an Australian Postgraduate Award scholarship to enable him to complete his 
studies. 
6. ‘Are there risks to me in taking part in this study?’
There are no physical risks associated with the study.  The focus groups and interviews will 
ask questions about the nature of acute stroke care within your workplace. You may refuse 
to answer any of the questions within any focus group or interview you attend, and you may 
take a break at any time during the study. Because of the nature of a focus group, 
confidentiality and privacy cannot be guaranteed.  However, all the participants will be 
asked to maintain the confidentiality of what is discussed within the group.   
7. ‘Will I benefit from the study?’
There are no direct benefits to you for being part of this study. It is hoped that the findings 
presented to participants, and the discussion occurring during focus groups may prompt a 
discussion among clinicians about the improving the quality of acute stroke care within their 
hospital. 
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8. ‘Will taking part in this study cost me anything, and will I be paid?
Participation in this study will not cost you anything. Your participation in the research is 
entirely voluntary. 
9. ‘How will my confidentiality be protected?’
• Given the nature of focus groups, the researchers cannot explicitly maintain
confidentiality. However, when the group comes together, agreed ways of working
will include maintaining confidentiality about what is discussed within the group.
• Any information that is obtained in connection with participation in the focus groups
or workshops will not include identifying information.
• Where interviews are concerned, any identifying information we may hold (e.g. your
name, position, employer) will be removed before any reporting or publication of
data. Your interview transcript will also be coded with a unique identification
number.
• Data will be held securely on a password protected computer at a UTAS office, and
only accessible to the research team. Hard copies of interview transcripts will be
kept in a locked filing cabinet in the locked office of the researcher, Mitchell Dwyer
10. ‘What happens with the results?’
The results will form part of the PhD candidate’s final thesis. Results of the study may also 
be published in peer-reviewed journals or presented at academic conferences. In any 
publication, information will be provided in such a way that you cannot be identified.  
11. ‘What should I do if I want to discuss this study further before I decide?’
When you have read this information, you will be provided an opportunity to ask questions 
and any queries you may have can be answered. If you would like to know more at any 
stage, please do not hesitate to contact Mitchell Dwyer on 04........... 
12. ‘Who should I contact if I have concerns about the conduct of this study?’
This study has been approved by the Tasmanian Health and Medical Human Research Ethics 
Committee.  If you have concerns or complaints about the conduct of this study you should 
contact the Executive Officer of the HREC (Tasmania) Network on (03) 6226 6254 or email 
human.ethics@utas.edu.au.  The Executive Officer is the person nominated to receive 
complaints from research participants. You will need to quote H0017665. 
Thank you for taking the time to consider this study. 
This information sheet is for you to keep. 
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Appendix H. Co-investigators and other contributors to the Australian Stroke 
Clinical Registry (Chapter Five) 
The following people are acknowledged for their contribution to collecting hospital data on the 
patients registered in AuSCR or their participation on various governance committees between 2010 
and 2015:  
  
Steering and Management Committee  
 
Craig Anderson PhD (Royal Prince Alfred Hospital NSW, site investigator, The George 
Institute for Global Health University of NSW, The George Institute for Global Health at 
Peking University Health Science Center China); Dominique Cadilhac PhD (Stroke and 
Ageing Research, School of Clinical Sciences at Monash Health, Monash University VIC, 
Stroke Division, The Florey Institute of Neuroscience and Mental Health VIC, Data 
Custodian); Geoffrey Donnan MD (Stroke Division, The Florey Institute of Neuroscience 
and Mental Health VIC); Rohan Grimley MBBS (Gympie Hospital QLD, Nambour General 
Hospital QLD, site investigator, Sunshine Coast Clinical School, University of Queensland 
QLD); Peter Hand MBBS, MD, FRACP (Royal Melbourne Hospital VIC, site investigator) 
 
Steering Committee  
 
Julie Bernhardt PhD (The Florey Institute of Neuroscience and Mental Health VIC); Paul 
Bew MPhty (The Prince Charles Hospital QLD); Christopher Bladin MD, MBBS, FRACP 
(Box Hill Hospital VIC, site investigator); Greg Cadigan BN (Queensland State-wide Stroke 
Clinical Network QLD); Helen Castley MBBS (Royal Hobart Hospital Tasmania, site 
investigator); Andrew Evans MBBS (Hons), FRACP (Westmead Hospital NSW); Susan 
Hillier PhD (University of South Australia, SA); Erin Lalor PhD (Stroke Foundation VIC); 
Andrew Lee MBBS FRACP (Flinders Medical Centre, South Australia); Richard Lindley 
PhD (The George Institute for Global Health NSW); Mark Mackay MBBS, FRACP (Royal 
Children’s Hospital VIC, site investigator); Sandra Martyn (Health Statistics Centre 
Queensland Health QLD); John McNeil PhD (Monash University VIC); Sandy Middleton 
PhD (Nursing Research Institute, St Vincent’s Health Australia NSW, Australian Catholic 
University NSW); Michael Pollack MBBS, FAFRM (RACP), FACRM, FFPM (ANZCA), 
MMedSci (Clin Epi) (Hunter Stroke Service NSW); Mark Simcocks BSc (VIC, Consumer 
Representative); Frances Simmonds MSc(Med), (Australasian Rehabilitation Outcomes 
Centre NSW); Amanda Thrift PhD (Stroke and Ageing Research, School of Clinical 
Sciences at Monash Health, Monash University VIC); Andrew Wesseldine MBBS, FRACP 
(St John of God Healthcare; Department of Health WA) 
 
Management Committee  
 
Helen Dewey PhD (Austin Hospital VIC, Box Hill Hospital VIC, site investigator, Eastern 
Health Clinical School, Monash University VIC); Steven Faux FAFRM (RACP) (St 
Vincent’s Health Australia NSW); Kelvin Hill BAppSci (Stroke Foundation VIC); Natasha 
Lannin PhD (Faculty of Health Sciences, La Trobe University VIC, Occupational Therapy 
Department, Alfred Health VIC); Christopher Levi PhD (Acute Stroke Services, John 





Lauren Arthurson BSpPath, MHlthServMt (Echuca Regional Health VIC); Pradeep 
Bambery MD, FRCP(G), FRACP (Bundaberg Hospital QLD); Tim Bates MBBS, FRACP 
(Swan District Hospital WA); Carolyn Beltrame RN (Div1) (Latrobe Regional Hospital 
VIC); David Blacker MBBS, FRACP (Sir Charles Gairdner Hospital WA); Ernie Butler 
MBBS FRACP (Peninsula Health VIC); Sean Butler FIMLS, BM Hons, MRCP(UK), 
FRACP (Prince Charles Hospital QLD); Chris Charnley MBBS (Warrnambool Base 
Hospital VIC); Jo Cotterell BPhysio (Mildura Base Hospital VIC); Douglas Crompton 
MA, PhD, MBBS, FRACP (Northern Hospital VIC); Vanessa Crosby Dip Physio (Albury-
Wodonga Health VIC); Carolyn De Wytt MRCP (UK), MB BCH DUBL, FRACP 
(Greenslopes Private Hospital QLD); David Douglas MBBS, M Admin, FRACGP, FAFRM 
(RACP) (Ipswich Hospital QLD); Martin Dunlop MBBS, FACRM (Cairns Base Hospital 
QLD); Paula Easton BPhty (Hons) (Mackay Hospital QLD); Sharan Ermel RN (Div1) 
(Bendigo Health VIC); Nisal Gange MBBS, AMC CERT (Toowoomba Hospital QLD); 
Richard Geraghty MBBS, FRACP (Redcliffe Hospital QLD); Melissa Gill BAppSc 
(SpPath) (Armidale Hospital, NSW); Graham Hall MBBS, FRACP (Princess Alexandra 
Hospital QLD); Geoffrey Herkes MBBS, PhD, FRACP (Royal North Shore Hospital NSW); 
Karen Hines BHIM (Caboolture Hospital QLD); Francis Hishon RN (Redland Hospital 
QLD); James Hughes BMed, FRACP (Tamworth Hospital NSW); Joel Iedema MBBS, 
FRACP (Redland Hospital QLD); Martin Jude MBBS, FRACP (Wagga Wagga Hospital 
NSW); Thomas Kraemer Approbation als Arzt, STATE EXAM MED MUNSTER, FRACP 
(Ballarat Health Services VIC); Paul Laird MBBS, FRACP (Rockhampton Hospital QLD); 
Johanna Madden BPhysio (Goulburn Valley Health VIC); Graham Mahaffey RN (Hervey 
Bay Hospital QLD); Suzana Milosevic MD, FRACP, AMC CERT (Logan Hospital QLD); 
Peter O’Brien MBBS, DIP RANZCOG, FRACMA, FACRRM (Warrnambool Hospital 
VIC); Trisha Oxley RN/RM, MANP (Critical Care) (Swan Hill District Health VIC); 
Michaela Plante RN (Div 1) (Rockhampton Hospital QLD); Juan Rois-Gnecco Medico 
Cirujano Javeriana, FAFRM (Ipswich Hospital QLD); Stephen Read MBBS, PhD, FRACP 
(Royal Brisbane and Women’s Hospital QLD); Kristen Rowe BNurs, Cert NeuroSci Nurs 
(Austin Health VIC); Fiona Ryan BAppSc (SpPath), MHlthSc (Orange Hospital and 
Bathurst Hospitals NSW); Arman Sabet MD, FRACP, BSc (Gold Coast Hospital and 
Robina Hospital QLD); Noel Saines MBBS, FRACP (The Wesley Hospital QLD); Eva 
Salud MD, AMC CERT (Gympie Hospital QLD); Amanda Siller MBBS, FRACP (Queen 
Elizabeth II Jubilee Hospital QLD); Christopher Staples MD (Mater Adults QLD); 
Amanda Styles RN (Div 1) (Armidale Hospital NSW); Judith Walloscheck MBA (Bendigo 
Health VIC); Richard White MD, FRCP, FRACP. (Townsville Hospital QLD); Andrew 
Wong MBBS, PhD (Royal Brisbane and Women’s Hospital QLD); Lillian Wong MBBS 
FRACP (Logan Hospital QLD) 
 
Staff at The Florey Institute of Neuroscience and Mental Health VIC 
 
Robin Armstrong, Leonid Churilov, Alison Dias, Kelly Drennan, Adele Gibbs, Brenda 
Grabsch, Jen Holland, Monique Kilkenny, Joosup Kim, Charlotte Krenus, Francis Kung, 
Joyce Lim, Karen Moss, Kate Paice, Enna Salama, Sam Shehata, Sabrina Small, Renee 
Stojanovic, Steven Street, Emma Tod, Kasey Wallis, Julia Watt 
 



































































































Appendix J. Flow Diagrams of AuSCR Participant Follow-up (2010-2015) 
(Chapter Five) 
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